phenotypeId,webApiCohortId,cohortName,logicDescription,cohortId,referentConceptId,cohortType,PMID
132702000,18641,Erythema multiforme referent incident cohort,"Persons with condition occurrence of referent concept (132702) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",132702001,132702,referent,
132702000,18640,Erythema multiforme referent prevalent cohort,"Persons with condition occurrence of referent concept (132702) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",132702002,132702,referent,
132702000,18998,Erythema multiforme or Stevens-Johnson syndrome design diagnostics 1 cohort,Erythema multiforme or Stevens-Johnson syndrome,132702003,132702,design diagnostics,
132703000,17549,Lichen planus referent incident cohort,"Persons with condition occurrence of referent concept (132703) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",132703001,132703,referent,
132703000,17548,Lichen planus referent prevalent cohort,"Persons with condition occurrence of referent concept (132703) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",132703002,132703,referent,
132703000,17062,Lichen Planus (LP) with second occurrence within 365 days,Lichen Planus with second occurrence within 365 days after. Cohort exit is the end of continuous observable time for the person.,132703003,132703,,
133444000,18707,Thyroiditis referent incident cohort,"Persons with condition occurrence of referent concept (133444) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",133444001,133444,referent,
133444000,18706,Thyroiditis referent prevalent cohort,"Persons with condition occurrence of referent concept (133444) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",133444002,133444,referent,
134442000,17681,Systemic sclerosis referent incident cohort,"Persons with condition occurrence of referent concept (134442) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",134442001,134442,referent,
134442000,17680,Systemic sclerosis referent prevalent cohort,"Persons with condition occurrence of referent concept (134442) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",134442002,134442,referent,
134442000,11954,Localized Scleroderma or Morphea at first diagnosis,Scleroderma at first diagnosis with 365 days continuous observation. Cohort exit is the end of continuous observable time for the person.,134442003,134442,,
134442000,17170,Systemic sclerosis at first diagnosis,Systemic sclerosis at first diagnosis at first diagnosis with 365 days continuous observation. Cohort exit is the end of continuous observable time for the person.,134442004,134442,,
134442000,17171,Systemic sclerosis or or localized scleroderma at first diagnosis,Systemic sclerosis or Scleroderma at first diagnosis at first diagnosis with 365 days continuous observation. Cohort exit is the end of continuous observable time for the person.,134442005,134442,,
136774000,17627,Pityriasis rubra pilaris referent incident cohort,"Persons with condition occurrence of referent concept (136774) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",136774001,136774,referent,
136774000,17626,Pityriasis rubra pilaris referent prevalent cohort,"Persons with condition occurrence of referent concept (136774) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",136774002,136774,referent,
138379000,17443,Chronic lymphoid leukemia referent incident cohort,"Persons with condition occurrence of referent concept (138379) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",138379001,138379,referent,
138379000,17442,Chronic lymphoid leukemia referent prevalent cohort,"Persons with condition occurrence of referent concept (138379) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",138379002,138379,referent,
138379000,17877,Chronic lymphoid leukemia design diagnostics 1 cohort,"Chronic lymphoid leukemia, disease referent concept prevalent cohort: First occurrence of updated concept set + descendants",138379003,138379,design diagnostics,
138502000,17711,Vitiligo referent incident cohort,"Persons with condition occurrence of referent concept (138502) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",138502001,138502,referent,
138502000,17710,Vitiligo referent prevalent cohort,"Persons with condition occurrence of referent concept (138502) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",138502002,138502,referent,
138502000,11660,Vitiligo (excludes around the eyelid and periocular) at first diagnosis,Vitiligo (excludes around the eyelid and periocular) at first diagnosis at first diagnosis with 365 days continuous observation. Cohort exit is the end of continuous observable time for the person.,138502003,138502,,
139899000,17621,Pemphigoid referent incident cohort,"Persons with condition occurrence of referent concept (139899) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",139899001,139899,referent,
139899000,17620,Pemphigoid referent prevalent cohort,"Persons with condition occurrence of referent concept (139899) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",139899002,139899,referent,
140168000,17637,Psoriasis referent incident cohort,"Persons with condition occurrence of referent concept (140168) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",140168001,140168,referent,
140168000,17636,Psoriasis referent prevalent cohort,"Persons with condition occurrence of referent concept (140168) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",140168002,140168,referent,
140168000,11643,Psoriasis at first diagnosis (no history of Psoriasis),"Psoriasis at first diagnosis with 365 days continuous observation, with no history of psoriasis. Cohort exit is the end of continuous observable time for the person.",140168003,140168,,
140168000,16411,"Psoriasis, exclude parapsoriasis and less common psoriasis subtypes specifically guttate psoriasis, generalized pustular psoriasis","Psoriasis at first diagnosis with 365 days continuous observation. Exclude persons with parapsoriasis, guttate psoriasis, generalized pustular psoriasis at any time. Cohort exit is the end of continuous observable time for the person.",140168004,140168,,
140168000,18434,Psoriasis excluding Guttate Psoriasis and Palmoplantar Pustulosis,Psoriasis at first diagnosis with 365 days continuous observation. Exclude persons with guttate psoriasis and palmoplantar pustuolosis at any time. Cohort exit is the end of continuous observable time for the person.,140168005,140168,,
140168000,18809,Psoriasis Elder 1,Psoriasis Eder (2020) 1+ codes,140168006,140168,literature,32062600
140168000,18810,Psoriasis Elder 2,Psoriasis Eder (2020) 1+ codes in-patient or 2+ codes out-patient,140168007,140168,literature,32062600
140168000,18811,Psoriasis Elder 3,Psoriasis Eder (2020) 1+ codes in-patient or 3+ codes out-patient,140168008,140168,literature,32062600
140168000,18812,Psoriasis Icen 1,Psoriasis Icen (2008) 1+ codes,140168009,140168,literature,18835060
140168000,18813,Psoriasis Seminara 1,Psoriasis Seminara (2011) 1+ codes,140168010,140168,literature,21073449
140168000,18814,Psoriasis Seminara 2,Psoriasis Seminara (2011) 2+ codes (on different dates),140168011,140168,literature,21073449
140168000,18815,Psoriasis Seminara 3,Psoriasis Seminara (2011) 3+ codes,140168012,140168,literature,21073449
140168000,17649,Pustular psoriasis referent incident cohort,"Persons with condition occurrence of referent concept (4063434) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4063434001,4063434,referent,
140168000,17648,Pustular psoriasis referent prevalent cohort,"Persons with condition occurrence of referent concept (4063434) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4063434002,4063434,referent,
140168000,16865,Pustular psoriasis of palms and soles at first diagnosis,Pustular psoriasis of palms and soles at first diagnosis with 365 days continuous observation. Cohort exit is the end of continuous observable time for the person.,4063434003,4063434,,
140168000,17310,Pustular Psoriasis with second occurrence within 365 days,Pustular Psoriasis with second occurrence within 365 days,4063434005,4063434,,
140168000,18307,Pustular psoriasis of palms and soles referent incident cohort,Pustular Psoriasis at first diagnosis with 365 days continuous observation. Cohort exit is the end of continuous observable time for the person.,4063434006,4100184,referent,
140168000,18308,Pustular psoriasis of palms and soles referent prevalent cohort,Pustular Psoriasis at first diagnosis with 365 days continuous observation. Cohort exit is the end of continuous observable time for the person.,4063434007,4063434,referent,
140168000,17499,Guttate psoriasis referent incident cohort,"Persons with condition occurrence of referent concept (4284492) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4284492001,4284492,referent,
140168000,17498,Guttate psoriasis referent prevalent cohort,"Persons with condition occurrence of referent concept (4284492) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4284492002,4284492,referent,
140168000,11652,Guttate psoriasis at first diagnosis,Guttate psoriasis at first diagnosis with 365 days continuous observation. Cohort exit is the end of continuous observable time for the person.,4284492003,4284492,,
140673000,17527,Hypothyroidism referent incident cohort,"Persons with condition occurrence of referent concept (140673) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",140673001,140673,referent,
140673000,17526,Hypothyroidism referent prevalent cohort,"Persons with condition occurrence of referent concept (140673) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",140673002,140673,referent,
141232000,17555,Malignant melanoma of skin referent incident cohort,"Persons with condition occurrence of referent concept (141232) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",141232001,141232,referent,
141232000,17554,Malignant melanoma of skin referent prevalent cohort,"Persons with condition occurrence of referent concept (141232) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",141232002,141232,referent,
141456000,18631,Chilblains referent incident cohort,"Persons with condition occurrence of referent concept (141456) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",141456001,141456,referent,
141456000,18630,Chilblains referent prevalent cohort,"Persons with condition occurrence of referent concept (141456) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",141456002,141456,referent,
141933000,17393,Alopecia areata referent incident cohort,"Persons with condition occurrence of referent concept (141933) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",141933001,141933,referent,
141933000,17392,Alopecia areata referent prevalent cohort,"Persons with condition occurrence of referent concept (141933) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",141933002,141933,referent,
141933000,17166,Alopecia (not including specific alopecia that suggest anything other than Alopecia Areata or non scarring alopecia) first diagnosis,Non-scarring Alopecia at first diagnosis with 365 days continuous observation. Cohort exit is the end of continuous observable time for the person.,141933003,141933,,
192671000,17493,Gastrointestinal hemorrhage referent incident cohort,"Persons with condition occurrence of referent concept (192671) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",192671001,192671,referent,
192671000,17492,Gastrointestinal hemorrhage referent prevalent cohort,"Persons with condition occurrence of referent concept (192671) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",192671002,192671,referent,
192671000,17748,"Gastrointestinal bleeding events, defined by condition occurrences of Gastrointestinal hemorrhage GI bleeding conceptset occurring between start and end of inpatient or ER visit","Gastrointestinal bleeding events, defined by condition occurrences of 'Gastrointestinal hemorrhage GI bleeding' conceptset occurring between start and end of inpatient or ER visit",192671003,192671,,
192671000,18910,"Gastrointestinal hemorrhage by Siontis Circulation, 2018",Gastrointestinal bleeding concept set with an inclusion criteria of inpatients visit on the day of,192671004,192671,literature,
192671000,19006,"Gastrointestinal hemorrhage adding Rectal hemorrhage and ER visits to Siontis, 2018",Gastrointestinal hemorrhage,192671005,192671,literature,
192675000,17427,Biliary cirrhosis referent incident cohort,"Persons with condition occurrence of referent concept (192675) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",192675001,192675,referent,
192675000,17426,Biliary cirrhosis referent prevalent cohort,"Persons with condition occurrence of referent concept (192675) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",192675002,192675,referent,
192675000,16923,"Primary biliary cirrhosis for first time in patients history, with exclusion of secondary biliary cirrhosis","Primary biliary cirrhosis at first diagnosis with 365 days continuous observation, exclusion of prior secondary biliary cirrhosis. Cohort exit is the end of continuous observable time for the person.",192675003,192675,,
192675000,16902,"Primary biliary cirrhosis for first time in patients history, with second occurrence of primary biliary cirrhosis within 2 years",Primary biliary cirrhosis with second occurrence of within two years after with 365 days continuous observation. Cohort exit is the end of continuous observable time for the person.,192675004,192675,,
194702000,18750,Premature rupture of membranes referent incident cohort,"Persons with condition occurrence of referent concept (194702) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",194702001,194702,referent,
194702000,18749,Premature rupture of membranes referent prevalent cohort,"Persons with condition occurrence of referent concept (194702) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",194702002,194702,referent,
194702000,18772,"Premature rupture of membranes events, females","Premature rupture of membranes events, females",194702003,194702,,
197508000,17575,Malignant tumor of urinary bladder referent incident cohort,"Persons with condition occurrence of referent concept (197508) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",197508001,197508,referent,
197508000,17574,Malignant tumor of urinary bladder referent prevalent cohort,"Persons with condition occurrence of referent concept (197508) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",197508002,197508,referent,
198984000,17563,Malignant tumor of cervix referent incident cohort,"Persons with condition occurrence of referent concept (198984) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",198984001,198984,referent,
198984000,17562,Malignant tumor of cervix referent prevalent cohort,"Persons with condition occurrence of referent concept (198984) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",198984002,198984,referent,
198985000,17633,Primary malignant neoplasm of kidney referent incident cohort,"Persons with condition occurrence of referent concept (198985) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",198985001,198985,referent,
198985000,17632,Primary malignant neoplasm of kidney referent prevalent cohort,"Persons with condition occurrence of referent concept (198985) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",198985002,198985,referent,
199074000,17381,Acute pancreatitis referent incident cohort,"Persons with condition occurrence of referent concept (199074) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",199074001,199074,referent,
199074000,17380,Acute pancreatitis referent prevalent cohort,"Persons with condition occurrence of referent concept (199074) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",199074002,199074,referent,
199074000,17747,Acute pancreatitis prevalent cohort: defined by condition occurrences of Acute pancreatitis conceptset occurring between start and end of inpatient or ER visit,,199074003,199074,,
201620000,17545,Kidney stone referent incident cohort,"Persons with condition occurrence of referent concept (201620) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",201620001,201620,referent,
201620000,17544,Kidney stone referent prevalent cohort,"Persons with condition occurrence of referent concept (201620) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",201620002,201620,referent,
201820000,17693,Type 1 diabetes mellitus referent incident cohort,"Persons with condition occurrence of referent concept (201254) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",201254001,201254,referent,
201820000,17692,Type 1 diabetes mellitus referent prevalent cohort,"Persons with condition occurrence of referent concept (201254) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",201254002,201254,referent,
201820000,18999,Type 1 diabetes mellitus design diagnostics 1 cohort,Type 1 diabetes,201254003,201254,design diagnostics,
201820000,17695,Type 2 diabetes mellitus referent incident cohort,"Persons with condition occurrence of referent concept (201826) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",201826001,201826,referent,
201820000,17694,Type 2 diabetes mellitus referent prevalent cohort,"Persons with condition occurrence of referent concept (201826) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",201826002,201826,referent,
201820000,17720,Type 2 diabetes mellitus prevalent cohort: First condition occurrence of Type 2 diabetes mellitus conceptset or observation of History of diabetes,,201826003,201826,,
201820000,18933,Type 2 diabetes mellitus incident cohort: First condition occurrence of Type 2 diabetes mellitus conceptset and no prior observation of History of diabetes,Type 2 diabetes mellitus incident cohort: First condition occurrence of 'Type 2 diabetes mellitus' conceptset and no prior observation of 'History of diabetes',201826004,201826,,
201820000,18934,Type 2 diabetes mellitus incident cohort: First condition occurrence of Type 2 diabetes mellitus conceptset or Type 2 diabetes treatment or HbA1c > 6.5 and no prior observation of History of diabetes,Type 2 diabetes mellitus incident cohort: First condition occurrence of 'Type 2 diabetes mellitus' conceptset or Type 2 diabetes treatment or HbA1c > 6.5 and no prior observation of 'History of diabetes',201826005,201826,,
201820000,18972,"Type 2 diabetes mellitus, pheKB 2012","Type 2 diabetes mellitus, pheKB 2012",201826006,201826,literature,
201820000,18964,Type 2 diabetes mellitus by Miller 2004,Prescription for a diabetes medication in the current year and/or 2+ diabetes codes from inpatient and/or outpatient visits over a 24-month period,201826007,201826,literature,
201820000,19031,Type 2 diabetes mellitus incident cohort: First condition occurrence of Type 2 diabetes mellitus conceptset or Type 2 diabetes treatment or HbA1c > 6.5 and no prior observation of History of diabetes and observation period of 365 days,Type 2 diabetes mellitus incident cohort: First condition occurrence of 'Type 2 diabetes mellitus' conceptset or Type 2 diabetes treatment or HbA1c > 6.5 and no prior observation of 'History of diabetes' and observation period of 365 days,201826008,201826,,
201820000,17467,Diabetic ketoacidosis referent incident cohort,"Persons with condition occurrence of referent concept (443727) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",443727001,443727,referent,
201820000,17466,Diabetic ketoacidosis referent prevalent cohort,"Persons with condition occurrence of referent concept (443727) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",443727002,443727,referent,
201820000,17798,Gestational diabetes mellitus referent incident cohort,"Persons with condition occurrence of referent concept (4024659) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4024659001,4024659,referent,
201820000,17797,Gestational diabetes mellitus referent prevalent cohort,"Persons with condition occurrence of referent concept (4024659) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4024659002,4024659,referent,
201820000,17762,"Gestational diabetes events, defined by condition occurrence of gestational diabetes conceptset in females",,4024659003,4024659,,
201965000,17673,Sepsis referent incident cohort,"Persons with condition occurrence of referent concept (132797) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",132797001,132797,referent,
201965000,17672,Sepsis referent prevalent cohort,"Persons with condition occurrence of referent concept (132797) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",132797002,132797,referent,
201965000,17728,"Sepsis during hospitalization, defined by condition occurrences of sepsis conceptset occurring between start and end of inpatient visit","Sepsis during hospitalization, defined by condition occurrences of 'sepsis' conceptset occurring between start and end of inpatient visit",132797003,132797,,
201965000,18629,Cardiogenic shock referent incident cohort,"Persons with condition occurrence of referent concept (198571) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",198571001,198571,referent,
201965000,18628,Cardiogenic shock referent prevalent cohort,"Persons with condition occurrence of referent concept (198571) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",198571002,198571,referent,
201965000,18604,"Cardiogenic shock by Vallabhajosyula, All events of Cardiogenic shock during inpatient or ER",not requiring MI,198571003,198571,literature,
201965000,18709,Toxic shock syndrome referent incident cohort,"Persons with condition occurrence of referent concept (201214) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",201214001,201214,referent,
201965000,18708,Toxic shock syndrome referent prevalent cohort,"Persons with condition occurrence of referent concept (201214) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",201214002,201214,referent,
201965000,17788,Cardiac arrest referent incident cohort,"Persons with condition occurrence of referent concept (321042) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",321042001,321042,referent,
201965000,17787,Cardiac arrest referent prevalent cohort,"Persons with condition occurrence of referent concept (321042) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",321042002,321042,referent,
201965000,18699,Systemic inflammatory response syndrome referent incident cohort,"Persons with condition occurrence of referent concept (434821) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",434821001,434821,referent,
201965000,18698,Systemic inflammatory response syndrome referent prevalent cohort,"Persons with condition occurrence of referent concept (434821) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",434821002,434821,referent,
24609000,17523,Hypoglycemia referent incident cohort,"Persons with condition occurrence of referent concept (24609) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",24609001,24609,referent,
24609000,17522,Hypoglycemia referent prevalent cohort,"Persons with condition occurrence of referent concept (24609) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",24609002,24609,referent,
24609000,17831,Hypoglycemia disorder concept design diagnostics 1 cohort,Hypoglycemic disorder at first diagnosis with 365 days continous observation. Cohort exist is the end of continous observable time for the person.,24609003,24609,design diagnostics,
254443000,18754,Sjögrens syndrome referent incident cohort,"Persons with condition occurrence of referent concept (254443) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",254443001,254443,referent,
254443000,18753,Sjögrens syndrome referent prevalent cohort,"Persons with condition occurrence of referent concept (254443) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",254443002,254443,referent,
254443000,8816,Sjogrens syndrome at first diagnosis,Sjogrens Syndrome at first diagnosis with 365 days continuous observation. Cohort exit is the end of continuous observable time for the person.,254443003,254443,,
254443000,18367,Sjogrens syndrome wtih keratoconjunctivitis sicca at first diagnosis,Sjogrens Syndrome with keratoconjunctivitis sicca at first diagnosis with 365 days continuous observation. Cohort exit is the end of continuous observable time for the person.,254443004,254443,,
255573000,17445,Chronic obstructive lung disease referent incident cohort,"Persons with condition occurrence of referent concept (255573) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",255573001,255573,referent,
255573000,17444,Chronic obstructive lung disease referent prevalent cohort,"Persons with condition occurrence of referent concept (255573) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",255573002,255573,referent,
255573000,17742,"Hospitalization for Chronic obstructive pulmonary disease, defined by inpatient visit with a primary condition occurrence of COPD conceptset",,255573003,255573,,
255573000,17766,"Chronic obstructive pulmonary disease (COPD) prevalent cohort, defined by condition occurrence of COPD or drug exposure for COPD mono- or combo-therapy at age>55 and no condition of asthma",,255573004,255573,,
255848000,17629,Pneumonia referent incident cohort,"Persons with condition occurrence of referent concept (255848) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",255848001,255848,referent,
255848000,17628,Pneumonia referent prevalent cohort,"Persons with condition occurrence of referent concept (255848) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",255848002,255848,referent,
255848000,17727,"Pneumonia during hospitalization, defined by condition occurrences of Pneumonia conceptset occurring between start and end of inpatient visit",,255848003,255848,,
255848000,17743,"Pneumonia prevalent cohort: Episodes of pneumonia, defined by condition occurrences of pneumonia conceptset",,255848004,255848,,
257628000,17679,Systemic lupus erythematosus referent incident cohort,"Persons with condition occurrence of referent concept (257628) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",257628001,257628,referent,
257628000,17678,Systemic lupus erythematosus referent prevalent cohort,"Persons with condition occurrence of referent concept (257628) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",257628002,257628,referent,
257628000,13719,Systemic lupus erythematosus (SLE) at first diagnosis,Systemic Lupus Erythematosus at first diagnosis with 365 days continuous observation. Cohort exit is the end of continuous observable time for the person.,257628003,257628,,
257628000,18544,"Systemic lupus erythematosus (SLE) as per Hanly et al (Canada, 2014)",,257628004,257628,literature,
257628000,18551,"Systemic lupus erythematosus (SLE) as per Klein et al (US, 2010)",,257628005,257628,literature,
257628000,18559,"Systemic lupus erythematosus (SLE), Incident as per Rees et al (UK, 2016)",,257628006,257628,literature,
257628000,18605,Systemic lupus erythematosus (SLE) as per Chibnik et al (2 diagnoses of SLE),,257628007,257628,literature,
257628000,18826,Systemic Lupus Erythmatosus Hanly 1,Systemic Lupus Erythematosus Hanly (2014) 2+ codes least 2 months apart,257628008,257628,literature,25057038
257628000,18827,Systemic Lupus Erythmatosus Hanly 2,Systemic Lupus Erythematosus Hanly (2014) 3+ codes,257628009,257628,literature,25057038
257628000,18828,Systemic Lupus Erythmatosus Hanly 3,Systemic Lupus Erythematosus Hanly (2014) 1+ codes,257628010,257628,literature,25057038
257628000,18829,Systemic Lupus Erythmatosis Jorge 1,Systemic Lupus Erythematosus Jorge (2019) 4+ codes and ever antimalarial use,257628011,257628,literature,30665626
257628000,18830,Systemic Lupus Erythmatosis Jorge 2,Systemic Lupus Erythematosus Jorge (2019) 3+ codes and ever antimalarial use,257628012,257628,literature,30665626
257628000,18831,Systemic Lupus Erythmatosis Jorge 3,Systemic Lupus Erythematosus Jorge (2019) 3+ codes and ever DMARD use and ever steroid use,257628013,257628,literature,30665626
257628000,18832,Systemic Lupus Erythmatosis Jorge 4,Systemic Lupus Erythematosus Jorge (2019) 4+ codes and ever DMARD use and ever steroid use,257628014,257628,literature,30665626
312939000,18703,Thromboangiitis obliterans referent incident cohort,"Persons with condition occurrence of referent concept (312939) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",312939001,312939,referent,
312939000,18702,Thromboangiitis obliterans referent prevalent cohort,"Persons with condition occurrence of referent concept (312939) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",312939002,312939,referent,
313459000,17677,Sleep apnea referent incident cohort,"Persons with condition occurrence of referent concept (313459) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",313459001,313459,referent,
313459000,17676,Sleep apnea referent prevalent cohort,"Persons with condition occurrence of referent concept (313459) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",313459002,313459,referent,
313800000,18705,Thrombotic microangiopathy referent incident cohort,"Persons with condition occurrence of referent concept (313800) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",313800001,313800,referent,
313800000,18704,Thrombotic microangiopathy referent prevalent cohort,"Persons with condition occurrence of referent concept (313800) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",313800002,313800,referent,
313800000,18570,"Thrombotic microangiopathy events, based on diagnosis codes from Reynolds AJKD 2003 and Perkins NDT 2006",,313800003,313800,literature,
316139000,17505,Heart failure referent incident cohort,"Persons with condition occurrence of referent concept (316139) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",316139001,316139,referent,
316139000,17504,Heart failure referent prevalent cohort,"Persons with condition occurrence of referent concept (316139) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",316139002,316139,referent,
316139000,17734,"Heart failure during hospitalization, defined by condition occurrences of Heart Failure conceptset occurring between start and end of inpatient visit","Heart failure during hospitalization, defined by condition occurrences of 'Heart Failure' conceptset occurring between start and end of inpatient visit",316139003,316139,,
316139000,7369,"Heart failure prevalent cohort, defined as the earliest condition occurrence of Heart Failure conceptset with a second condition occurrence in the 365d after entry","Heart failure prevalent cohort, defined as the earliest condition occurrence of 'Heart Failure' conceptset with a second condition occurrence in the 365d after entry",316139004,316139,,
316866000,17521,Hypertensive disorder referent incident cohort,"Persons with condition occurrence of referent concept (316866) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",316866001,316866,referent,
316866000,17520,Hypertensive disorder referent prevalent cohort,"Persons with condition occurrence of referent concept (316866) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",316866002,316866,referent,
316866000,17760,Hypertensive disorder prevalent cohort: First condition occurrence of Hypertension conceptset,,316866003,316866,,
318443000,17409,Arteriosclerotic vascular disease referent incident cohort,"Persons with condition occurrence of referent concept (318443) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",318443001,318443,referent,
318443000,17408,Arteriosclerotic vascular disease referent prevalent cohort,"Persons with condition occurrence of referent concept (318443) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",318443002,318443,referent,
318736000,17583,Migraine referent incident cohort,"Persons with condition occurrence of referent concept (318736) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",318736001,318736,referent,
318736000,17582,Migraine referent prevalent cohort,"Persons with condition occurrence of referent concept (318736) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",318736002,318736,referent,
318736000,17843,Migraine design diagnostics 1 cohort,First occurrence of 'Migraine excluding abdominal migraine'+ descendants excluding abdominal migraine with >=365d prior observation,318736003,318736,design diagnostics,
318800000,17491,Gastroesophageal reflux disease referent incident cohort,"Persons with condition occurrence of referent concept (318800) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",318800001,318800,referent,
318800000,17490,Gastroesophageal reflux disease referent prevalent cohort,"Persons with condition occurrence of referent concept (318800) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",318800002,318800,referent,
319041000,17609,Orthostatic hypotension referent incident cohort,"Persons with condition occurrence of referent concept (319041) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",319041001,319041,referent,
319041000,17608,Orthostatic hypotension referent prevalent cohort,"Persons with condition occurrence of referent concept (319041) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",319041002,319041,referent,
321052000,17625,Peripheral vascular disease referent incident cohort,"Persons with condition occurrence of referent concept (321052) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",321052001,321052,referent,
321052000,17624,Peripheral vascular disease referent prevalent cohort,"Persons with condition occurrence of referent concept (321052) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",321052002,321052,referent,
321052000,18746,Peripheral ischemia referent incident cohort,"Persons with condition occurrence of referent concept (4124836) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4124836001,4124836,referent,
321052000,18745,Peripheral ischemia referent prevalent cohort,"Persons with condition occurrence of referent concept (4124836) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4124836002,4124836,referent,
321319000,18701,Takotsubo cardiomyopathy referent incident cohort,"Persons with condition occurrence of referent concept (40479589) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",40479589001,40479589,referent,
321319000,18700,Takotsubo cardiomyopathy referent prevalent cohort,"Persons with condition occurrence of referent concept (40479589) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",40479589002,40479589,referent,
321319000,18561,Stress Cardiomyopathy as per Bhat et al (US 2020),,40479589003,40479589,literature,
36712702000,18695,Preterm labor with preterm delivery referent incident cohort,"Persons with condition occurrence of referent concept (36712702) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",36712702001,36712702,referent,
36712702000,18694,Preterm labor with preterm delivery referent prevalent cohort,"Persons with condition occurrence of referent concept (36712702) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",36712702002,36712702,referent,
372328000,17615,Otitis media referent incident cohort,"Persons with condition occurrence of referent concept (372328) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",372328001,372328,referent,
372328000,17614,Otitis media referent prevalent cohort,"Persons with condition occurrence of referent concept (372328) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",372328002,372328,referent,
37311061000,17794,Disease caused by 2019-nCoV referent incident cohort,"Persons with condition occurrence of referent concept (37311061) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",37311061001,37311061,referent,
37311061000,17793,Disease caused by 2019-nCoV referent prevalent cohort,"Persons with condition occurrence of referent concept (37311061) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",37311061002,37311061,referent,
37311061000,18774,Persons tested positive for SARS-CoV-2 with at least 365d prior observation,,37311061003,37311061,,
37311061000,18776,Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test,,37311061004,37311061,,
37311061000,18777,Persons with a COVID-19 diagnosis or a SARS-CoV-2 positive test with no required prior observation,,37311061005,37311061,,
37436000,18683,Optic neuritis referent incident cohort,"Persons with condition occurrence of referent concept (374954) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",374954001,374954,referent,
37436000,18682,Optic neuritis referent prevalent cohort,"Persons with condition occurrence of referent concept (374954) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",374954002,374954,referent,
37436000,18521,Optic neuritis by Lin (codes + either 3 Otpt or 1 inpatient),,374954003,374954,,
374366000,18697,Sensorineural hearing loss referent incident cohort,"Persons with condition occurrence of referent concept (374366) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",374366001,374366,referent,
374366000,18696,Sensorineural hearing loss referent prevalent cohort,"Persons with condition occurrence of referent concept (374366) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",374366002,374366,referent,
375801000,17587,Multiple sclerosis referent incident cohort,"Persons with condition occurrence of referent concept (374919) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",374919001,374919,referent,
375801000,17586,Multiple sclerosis referent prevalent cohort,"Persons with condition occurrence of referent concept (374919) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",374919002,374919,referent,
375801000,17093,Multiple Sclerosis (MS) at first diagnosis,Multiple Sclerosis (MS) at first diagnosis with 365 days continuous observation. Cohort exit is the end of continuous observable time for the person.,374919003,374919,,
375801000,18542,"Persons with multiple sclerosis, as defined by Widdifield NSJ 2015",,374919004,374919,literature,
375801000,18633,Chronic inflammatory demyelinating polyradiculoneuropathy referent incident cohort,"Persons with condition occurrence of referent concept (381009) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",381009001,381009,referent,
375801000,18632,Chronic inflammatory demyelinating polyradiculoneuropathy referent prevalent cohort,"Persons with condition occurrence of referent concept (381009) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",381009002,381009,referent,
375806000,18657,Idiopathic peripheral neuropathy referent incident cohort,"Persons with condition occurrence of referent concept (375806) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",375806001,375806,referent,
375806000,18656,Idiopathic peripheral neuropathy referent prevalent cohort,"Persons with condition occurrence of referent concept (375806) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",375806002,375806,referent,
377091000,17671,Seizure referent incident cohort,"Persons with condition occurrence of referent concept (377091) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",377091001,377091,referent,
377091000,17670,Seizure referent prevalent cohort,"Persons with condition occurrence of referent concept (377091) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",377091002,377091,referent,
377091000,18502,"Seizure by Shui, Custom code and require an inpatient or an ER visit",,377091003,377091,literature,
377091000,17479,Epilepsy referent incident cohort,"Persons with condition occurrence of referent concept (380378) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",380378001,380378,referent,
377091000,17478,Epilepsy referent prevalent cohort,"Persons with condition occurrence of referent concept (380378) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",380378002,380378,referent,
377091000,17833,Epilepsy/seizure disorder design diagnostics 2 cohort,"Seizure disorder, epileptic seizure added. Excludes eclampsia, convulsions of new born and complications of pregnancy, childbirth and puerperium.",380378003,380378,design diagnostics,
377091000,17834,Epilepsy/seizure (adding parents with additional exclusions - require 2nd Dx within 30 days),"Seizure disorder, epileptic seizure added. Excludes eclampsia, convulsions of new born and complications of pregnancy, childbirth and puerperium (require 2nd Dx within 30 days)",380378004,380378,data diagnostics,
377091000,18379,Epilepsy design diagnostics 1 cohort,Epilepsy incident cohort: First occurrence of Seizures (excludes concept that may represent a short term seizures) + descendants with >=365d prior observation,380378005,380378,design diagnostics,
377091000,18833,Epilepsy Christensen 1,Epilepsy Christensen (2007) 1+ codes,380378006,380378,literature,
377091000,18834,Epilepsy Jette 1,Epilepsy Jette (2010) 1+ codes inpatient,380378007,380378,literature,
377091000,18835,Epilepsy Moura 1,Epilepsy Moura (2017) 1+ codes + Anti-Epileptic Drug,380378008,380378,literature,
377091000,18836,Epilepsy Pugh 1,Epilepsy Pugh (2008) 1+ codes + Anti-Epileptic Drug,380378009,380378,literature,
377091000,18837,Epilepsy Tan 1,Epilepsy Tan (2015) 1+ codes in-patient,380378010,380378,literature,
377091000,20092,FDA AESI seizure pediatric events,All events of Seizure with no such events in prior clean window period (42 days) and restricted to ages < 2 years. No continuous observation period requirement. Persons exit the cohort on start_date + 1 day.,380378011,4196708,study;FDA;Covid,
377091000,20093,FDA AESI seizure pediatric event episodes for incidence characterization,All events of Seizure restricted to ages < 2 years. No continuous observation period requirement. Persons exit the cohort on start_date + 42 days.,380378012,4196708,study;FDA;Covid,
377091000,20094,FDA AESI febrile seizure pediatric events,All events of Febrile Seizure with no such events in prior clean window period (42 days) and restricted to ages < 2 years. No continuous observation period requirement. Persons exit the cohort on start_date + 1 day.,380378013,444413,study;FDA;Covid,
377091000,20095,FDA AESI febrile seizure pediatric event episodes for incidence characterization,All events of Seizure restricted to ages < 2 years. No continuous observation period requirement. Persons exit the cohort on start_date + 42 days.,380378014,444413,study;FDA;Covid,
378135000,18643,Facial palsy referent incident cohort,"Persons with condition occurrence of referent concept (4091559) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4091559001,4091559,referent,
378135000,18642,Facial palsy referent prevalent cohort,"Persons with condition occurrence of referent concept (4091559) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4091559002,4091559,referent,
378135000,20060,FDA AESI Bells palsy events,All events of Bells palsy with no events in prior clean period (183 days). No continuous observation period requirement. Persons exit the cohort on start_date + 1 day. Includes both UMN and LMN palsy.,4091559003,374923,study;FDA;Covid,
378135000,20061,FDA AESI Bells palsy events for incidence characterization,All events of Bells palsy. No continuous observation period requirement. Persons exit the cohort on start_date + 183 days. Includes both UMN and LMN palsy.,4091559004,374923,study;FDA;Covid,
378416000,17389,Age related macular degeneration referent incident cohort,"Persons with condition occurrence of referent concept (374028) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",374028001,374028,referent,
378416000,17388,Age related macular degeneration referent prevalent cohort,"Persons with condition occurrence of referent concept (374028) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",374028002,374028,referent,
378416000,17659,Retinal detachment referent incident cohort,"Persons with condition occurrence of referent concept (378414) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",378414001,378414,referent,
378416000,17658,Retinal detachment referent prevalent cohort,"Persons with condition occurrence of referent concept (378414) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",378414002,378414,referent,
378416000,17661,Retinal disorder referent incident cohort,"Persons with condition occurrence of referent concept (378416) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",378416001,378416,referent,
378416000,17660,Retinal disorder referent prevalent cohort,"Persons with condition occurrence of referent concept (378416) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",378416002,378416,referent,
378416000,17663,Retinopathy due to diabetes mellitus referent incident cohort,"Persons with condition occurrence of referent concept (4174977) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4174977001,4174977,referent,
378416000,17662,Retinopathy due to diabetes mellitus referent prevalent cohort,"Persons with condition occurrence of referent concept (4174977) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4174977002,4174977,referent,
378416000,17459,Degeneration of retina referent incident cohort,"Persons with condition occurrence of referent concept (4318985) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4318985001,4318985,referent,
378416000,17458,Degeneration of retina referent prevalent cohort,"Persons with condition occurrence of referent concept (4318985) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4318985002,4318985,referent,
378419000,17395,Alzheimers disease referent incident cohort,"Persons with condition occurrence of referent concept (378419) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",378419001,378419,referent,
378419000,17394,Alzheimers disease referent prevalent cohort,"Persons with condition occurrence of referent concept (378419) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",378419002,378419,referent,
378419000,18982,"Alzheimers disease by Imfeld Epilepsia, 2013","Composite definition of Alzheimers disease, dementia or prescription for an alzheimer disease",378419003,378419,literature,
381114000,18663,Microcephalus referent incident cohort,"Persons with condition occurrence of referent concept (381114) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",381114001,381114,referent,
381114000,18662,Microcephalus referent prevalent cohort,"Persons with condition occurrence of referent concept (381114) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",381114002,381114,referent,
381270000,17619,Parkinsons disease referent incident cohort,"Persons with condition occurrence of referent concept (381270) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",381270001,381270,referent,
381270000,17618,Parkinsons disease referent prevalent cohort,"Persons with condition occurrence of referent concept (381270) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",381270002,381270,referent,
381591000,17820,Transient cerebral ischemia referent incident cohort,"Persons with condition occurrence of referent concept (373503) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",373503001,373503,referent,
381591000,17819,Transient cerebral ischemia referent prevalent cohort,"Persons with condition occurrence of referent concept (373503) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",373503002,373503,referent,
381591000,17750,"Transient ischemic attack events, defined by condition occurrences of Transient cerebral Ischemia (TCA) conceptset occurring between start and end of inpatient or ER visit",,373503003,373503,,
381591000,17435,Cerebral hemorrhage referent incident cohort,"Persons with condition occurrence of referent concept (376713) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",376713001,376713,referent,
381591000,17434,Cerebral hemorrhage referent prevalent cohort,"Persons with condition occurrence of referent concept (376713) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",376713002,376713,referent,
381591000,17752,"Hemorrhagic stroke events, defined by condition occurrences of intracranial bleed Hemorrhagic stroke conceptset occurring between start and end of inpatient or ER visit",,376713003,376713,,
381591000,18937,"Hemorrhagic stroke events, defined by condition occurrences of Intracranial Bleed Hemorrhagic Stroke conceptset","Hemorrhagic stroke events, defined by condition occurrences of 'Intracranial Bleed Hemorrhagic Stroke' conceptset",376713004,376713,,
381591000,17790,Cerebrovascular accident referent incident cohort,"Persons with condition occurrence of referent concept (381316) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",381316001,381316,referent,
381591000,17789,Cerebrovascular accident referent prevalent cohort,"Persons with condition occurrence of referent concept (381316) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",381316002,381316,referent,
381591000,17749,"Stroke events, defined by condition occurrences of Stroke (ischemic or hemorrhagic) conceptset occurring between start and end of inpatient or ER visit",,381316003,381316,,
381591000,17439,Cerebrovascular disease referent incident cohort,"Persons with condition occurrence of referent concept (381591) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",381591001,381591,referent,
381591000,17438,Cerebrovascular disease referent prevalent cohort,"Persons with condition occurrence of referent concept (381591) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",381591002,381591,referent,
381591000,17437,Cerebral infarction referent incident cohort,"Persons with condition occurrence of referent concept (443454) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",443454001,443454,referent,
381591000,17436,Cerebral infarction referent prevalent cohort,"Persons with condition occurrence of referent concept (443454) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",443454002,443454,referent,
381591000,17751,"Ischemic stroke events, defined by condition occurrences of Ischemic stroke conceptset occurring between start and end of inpatient or ER visit",,443454003,443454,,
381591000,18936,"Ischemic stroke events, defined by condition occurrences of Ischemic stroke conceptset","Ischemic stroke events, defined by condition occurrences of 'Ischemic stroke' conceptset",443454004,443454,,
381591000,20070,FDA AESI Non-hemorrhagic stroke IP events,All events of Non-hemorrhagic stroke (i.e. ischemic stroke) limited to events with overlapping inpatient stay with no such events in prior clean window period (365 days). No continuous observation period requirement. Persons exit the cohort on start_date + 1 day. Note: cerebral thrombosis (based on validated literature review),443454005,381316,study;FDA;Covid,
381591000,20071,FDA AESI Non-hemorrhagic stroke IP event episodes for incidence characterization,All events of Non-hemorrhagic stroke (i.e. ischemic stroke) limited to events with overlapping inpatient stay. No continuous observation period requirement. Persons exit the cohort on start_date + 365 days. Note: cerebral thrombosis (based on validated literature review),443454006,381316,study;FDA;Covid,
381591000,20072,FDA AESI Hemorrhagic stroke IP events,All events of Hemorrhagic stroke limited to events with overlapping inpatient stay with no such events in prior clean window period (365 days). No continuous observation period requirement. Persons exit the cohort on start_date + 1 day.,443454007,381316,study;FDA;Covid,
381591000,20073,FDA AESI Hemorrhagic stroke IP event episodes for incidence characterization,All events of hemorrhagic stroke limited to events with overlapping inpatient stay. No continuous observation period requirement. Persons exit the cohort on start_date + 365 days.,443454008,381316,study;FDA;Covid,
4013643000,17643,Pulmonary arterial hypertension referent incident cohort,"Persons with condition occurrence of referent concept (4013643) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4013643001,4013643,referent,
4013643000,17642,Pulmonary arterial hypertension referent prevalent cohort,"Persons with condition occurrence of referent concept (4013643) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4013643002,4013643,referent,
4027537000,18671,Myasthenia gravis referent incident cohort,"Persons with condition occurrence of referent concept (76685) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",76685001,76685,referent,
4027537000,18670,Myasthenia gravis referent prevalent cohort,"Persons with condition occurrence of referent concept (76685) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",76685002,76685,referent,
4027537000,18673,Myasthenic syndrome due to another disorder referent incident cohort,"Persons with condition occurrence of referent concept (432893) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",432893001,432893,referent,
4027537000,18672,Myasthenic syndrome due to another disorder referent prevalent cohort,"Persons with condition occurrence of referent concept (432893) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",432893002,432893,referent,
4028363000,17703,Uveitis referent incident cohort,"Persons with condition occurrence of referent concept (4028363) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4028363001,4028363,referent,
4028363000,17702,Uveitis referent prevalent cohort,"Persons with condition occurrence of referent concept (4028363) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4028363002,4028363,referent,
4028363000,11966,Uveitis at first diagnosis,Uveitis at first diagnosis with 365 days continuous observation. Cohort exit is the end of continuous observable time for the person.,4028363003,4028363,,
4028363000,18560,"Uveitits, Guo algorithm (codes on 2 visits at least 30 days apart)",,4028363004,4028363,literature,
4028363000,18550,"Uveitits, Pimentel algorithm (codes on any visit and no traumatic iritis or uveitis after ocular surgery)",,4028363005,4028363,,
4030518000,17651,Renal failure syndrome referent incident cohort,"Persons with condition occurrence of referent concept (192359) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",192359001,192359,referent,
4030518000,17650,Renal failure syndrome referent prevalent cohort,"Persons with condition occurrence of referent concept (192359) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",192359002,192359,referent,
4030518000,17796,End-stage renal disease referent incident cohort,"Persons with condition occurrence of referent concept (193782) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",193782001,193782,referent,
4030518000,17795,End-stage renal disease referent prevalent cohort,"Persons with condition occurrence of referent concept (193782) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",193782002,193782,referent,
4030518000,7374,End stage renal disease prevalent cohort: All condition occurrences of End stage renal disease conceptset with either a 2nd diagnosis of End stage renal disease or a record of Dialysis in 90d after,End stage renal disease prevalent cohort: All condition occurrences of 'End stage renal disease' conceptset with either a 2nd diagnosis of 'End stage renal disease' or a record of 'Dialysis' in 90d after,193782004,193782,,
4030518000,17755,End stage renal disease prevalent cohort: All condition occurrences or observations of End stage renal disease conceptset with either a 2nd diagnosis or observatoin of End stage renal disease or a record of Dialysis in 90d after,End stage renal disease prevalent cohort: All condition occurrences or observations of 'End stage renal disease' conceptset with either a 2nd diagnosis or observatoin of 'End stage renal disease' or a record of 'Dialysis' in 90d after,193782005,193782,,
4030518000,17383,Acute renal failure syndrome referent incident cohort,"Persons with condition occurrence of referent concept (197320) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",197320001,197320,referent,
4030518000,17382,Acute renal failure syndrome referent prevalent cohort,"Persons with condition occurrence of referent concept (197320) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",197320002,197320,referent,
4030518000,17729,"Acute kidney injury diagnosis during hospitalization, without prior end-stage renal disease or transplant","Acute kidney injury diagnosis during hospitalization, without prior end-stage renal disease or transplant",197320003,197320,,
4030518000,7382,"Acute kidney injury diagnosis during hospitalization, defined by condition occurrences of acute renal failure conceptset occurring between start and end of inpatient visit","Acute kidney injury diagnosis during hospitalization, defined by condition occurrences of 'acute renal failure' conceptset occurring between start and end of inpatient visit",197320004,197320,,
4030518000,17387,Acute tubular necrosis referent incident cohort,"Persons with condition occurrence of referent concept (444044) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",444044001,444044,referent,
4030518000,17386,Acute tubular necrosis referent prevalent cohort,"Persons with condition occurrence of referent concept (444044) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",444044002,444044,referent,
4030518000,17653,Renal impairment referent incident cohort,"Persons with condition occurrence of referent concept (4030518) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4030518001,4030518,referent,
4030518000,17652,Renal impairment referent prevalent cohort,"Persons with condition occurrence of referent concept (4030518) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4030518002,4030518,referent,
4030518000,17441,Chronic kidney disease referent incident cohort,"Persons with condition occurrence of referent concept (46271022) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",46271022001,46271022,referent,
4030518000,17440,Chronic kidney disease referent prevalent cohort,"Persons with condition occurrence of referent concept (46271022) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",46271022002,46271022,referent,
4030518000,17718,Chronic kidney disease prevalent cohort: First condition occurrence of chronic kidney disease conceptset,,46271022003,46271022,,
4030518000,17759,"Chronic kidney disease prevalent cohort: Earliest condition occurrence of chronic kidney disease conceptset, with a condition occurrence in 30d after to anytime after, or 3 or more dialysis events anytime on or after entry event",,46271022004,46271022,,
4030518000,17853,"Chronic kidney disease prevalent cohort: earliest CKD with evidence CKD 90d post-index, 2+ dialysis events 90d apart, 2+ kayexlate drug exposure 90d apart, or evidence of AV Fistula",,46271022005,46271022,,
4030518000,18938,Chronic kidney disease incident cohort: First condition occurrence of chronic kidney disease conceptset,Chronic kidney disease incident cohort: First condition occurrence of 'chronic kidney disease' conceptset,46271022006,46271022,,
4043371000,17477,Eosinophilic esophagitis referent incident cohort,"Persons with condition occurrence of referent concept (27918) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",27918001,27918,referent,
4043371000,17476,Eosinophilic esophagitis referent prevalent cohort,"Persons with condition occurrence of referent concept (27918) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",27918002,27918,referent,
4043371000,16908,Eosinophilic esophagitis with another occurrence in two years after - first time in persons history,Eosinophilic esophagitis at first diagnosis with 365 days continuous observation and a second diagnosis within 2 years. Cohort exit is the end of continuous observable time for the person.,27918003,27918,,
4043371000,17481,Esophagitis referent incident cohort,"Persons with condition occurrence of referent concept (30753) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",30753001,30753,referent,
4043371000,17480,Esophagitis referent prevalent cohort,"Persons with condition occurrence of referent concept (30753) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",30753002,30753,referent,
4043371000,17699,Ulcerative colitis referent incident cohort,"Persons with condition occurrence of referent concept (81893) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",81893001,81893,referent,
4043371000,17698,Ulcerative colitis referent prevalent cohort,"Persons with condition occurrence of referent concept (81893) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",81893002,81893,referent,
4043371000,10605,Ulcerative colitis at first diagnosis with no history of ulcerative colitis,Ulcerative colitis at first diagnosis with 365 days continous observation and no history of ulcerative colitis observation. Cohort exist is the end of continous observable time for the person.,81893003,81893,,
4043371000,15982,"Ulcerative colitis at first diagnosis with a second diagnosis at any time in future, no history of code",Ulcerative colitis at first diagnosis with 365 days continous observation and no history of ulcerative colitis observation with second occurrence at anytime after index date. Cohort exist is the end of continous observable time for the person.,81893004,81893,,
4043371000,18803,Ulcerative Colitis Ananthakrishnan 1,Ulcerative Colitis Ananthakrishnan (2013) 1+ codes,81893005,81893,literature,23567779
4043371000,18804,Ulcerative Colitis Ananthakrishnan 2,Ulcerative Colitis Ananthakrishnan (2013) 5+ codes,81893006,81893,literature,23567779
4043371000,18805,Ulcerative Colitis Ananthakrishnan 3,Ulcerative Colitis Ananthakrishnan (2013) 1+ codes + endoscopy,81893007,81893,literature,23567779
4043371000,18806,Ulcerative Colitis Ananthakrishnan 4,Ulcerative Colitis Ananthakrishnan (2013) 4+ codes out-patient or 2+ codes in-patient,81893008,81893,literature,23567779
4043371000,18807,Ulcerative Colitis Stepaniuk 1,Ulcerative Colitis Stepaniuk (2015) 1+ codes In-patient,81893009,81893,literature,25874650
4043371000,18808,Ulcerative Colitis Thirumurthi 1,Ulcerative Colitis Thirumurthi (2010) 1+ codes In-patient,81893010,81893,literature,20033847
4043371000,17433,Celiac disease referent incident cohort,"Persons with condition occurrence of referent concept (194992) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",194992001,194992,referent,
4043371000,17432,Celiac disease referent prevalent cohort,"Persons with condition occurrence of referent concept (194992) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",194992002,194992,referent,
4043371000,17489,Gastritis referent incident cohort,"Persons with condition occurrence of referent concept (201340) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",201340001,201340,referent,
4043371000,17488,Gastritis referent prevalent cohort,"Persons with condition occurrence of referent concept (201340) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",201340002,201340,referent,
4043371000,17455,Crohns disease referent incident cohort,"Persons with condition occurrence of referent concept (201606) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",201606001,201606,referent,
4043371000,17454,Crohns disease referent prevalent cohort,"Persons with condition occurrence of referent concept (201606) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",201606002,201606,referent,
4043371000,15078,Crohns disease for first time with no history (Thirumurthi),"Crohn's disease (validated concept set) at first diagnosis with 365 days continuous observation, with no history of crohn's disease. Cohort exit is the end of continuous observable time for the person.",201606003,201606,literature,20033847
4043371000,16402,Crohns disease for first time with 5 occurrences in 4 years after and no history of code (Benchimol),"Crohn's disease (validated concept set) at first diagnosis with 365 days continuous observation, with no history of crohn's disease, and atleast 4 visits in 4 years. Cohort exit is the end of continuous observable time for the person.",201606004,201606,literature,
4043371000,18820,Crohns Disease Ananthakrishnan 1,Crohns Disease Ananthakrishnan (2013) 1+ codes,201606005,201606,literature,23567779
4043371000,18821,Crohns Disease Ananthakrishnan 2,Crohns Disease Ananthakrishnan (2013) 5+ codes,201606006,201606,literature,23567779
4043371000,18822,Crohns Disease Ananthakrishnan 3,Crohns Disease Ananthakrishnan (2013) 1+ codes + endoscopy,201606007,201606,literature,23567779
4043371000,18823,Crohns Disease Ananthakrishnan 4,Crohns Disease Ananthakrishnan (2013) 4+ codes out-patient or 2+ codes in-patient,201606008,201606,literature,23567779
4043371000,18824,Crohns Disease Stepaniuk 1,Crohns Disease Stepaniuk (2015) 1+ codes In-patient,201606009,201606,literature,25874650
4043371000,18825,Crohns Disease Thirumurthi 1,Crohns Disease Thirumurthi (2010) 1+ codes In-patient,201606010,201606,literature,20033847
4043371000,17529,Inflammatory bowel disease referent incident cohort,"Persons with condition occurrence of referent concept (4074815) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4074815001,4074815,referent,
4043371000,17528,Inflammatory bowel disease referent prevalent cohort,"Persons with condition occurrence of referent concept (4074815) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4074815002,4074815,referent,
4043371000,17144,Inflammatory bowel disease,"Inflammatory Bowel Disease at first diagnosis with 365 days continuous observation and no prior history of IBM, CD or UC. Cohort exit is the end of continuous observable time for the person.",4074815003,4074815,,
4043371000,18637,Diverticulitis of large intestine referent incident cohort,"Persons with condition occurrence of referent concept (4260535) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4260535001,4260535,referent,
4043371000,18636,Diverticulitis of large intestine referent prevalent cohort,"Persons with condition occurrence of referent concept (4260535) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4260535002,4260535,referent,
4043371000,20066,FDA AESI Appendicitis IP events,All events of Appendicitis limited to events with overlapping inpatient stay with no such events in prior clean window period (365 days). No continuous observation period requirement. Persons exit the cohort on start_date + 1 day.,4260535003,440448,study;FDA;Covid,
4043371000,20067,FDA AESI Appendicitis IP event episodes for incidence characterization,All events of Appendicitis limited to events with overlapping inpatient sta. No continuous observation period requirement. Persons exit the cohort on start_date + 365 days.,4260535004,440448,study;FDA;Covid,
4046338000,18669,Motor neuropathy with multiple conduction block referent incident cohort,"Persons with condition occurrence of referent concept (4046338) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4046338001,4046338,referent,
4046338000,18668,Motor neuropathy with multiple conduction block referent prevalent cohort,"Persons with condition occurrence of referent concept (4046338) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4046338002,4046338,referent,
40481902000,17557,Malignant neoplasm of anorectum referent incident cohort,"Persons with condition occurrence of referent concept (40481902) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",40481902001,40481902,referent,
40481902000,17556,Malignant neoplasm of anorectum referent prevalent cohort,"Persons with condition occurrence of referent concept (40481902) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",40481902002,40481902,referent,
4067106000,17806,Miscarriage referent incident cohort,"Persons with condition occurrence of referent concept (4067106) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4067106001,4067106,referent,
4067106000,17805,Miscarriage referent prevalent cohort,"Persons with condition occurrence of referent concept (4067106) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4067106002,4067106,referent,
4067106000,17740,"Miscarriage or abortion events, defined by condition occurrences, observations, or procedures of Abortion conceptset in females",,4067106003,4067106,,
4092289000,17800,Livebirth referent incident cohort,"Persons with condition occurrence of referent concept (4092289) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4092289001,4092289,referent,
4092289000,17799,Livebirth referent prevalent cohort,"Persons with condition occurrence of referent concept (4092289) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4092289002,4092289,referent,
4094294000,17595,Neck pain referent incident cohort,"Persons with condition occurrence of referent concept (24134) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",24134001,24134,referent,
4094294000,17594,Neck pain referent prevalent cohort,"Persons with condition occurrence of referent concept (24134) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",24134002,24134,referent,
4094294000,18994,Neck pain (includes cervico-occipital neuralgia) design diagnostics 1 cohort,neck pain includes cervico-occipital neuralgia,24134003,24134,design diagnostics,
4094294000,17471,Dysphagia referent incident cohort,"Persons with condition occurrence of referent concept (31317) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",31317001,31317,referent,
4094294000,17470,Dysphagia referent prevalent cohort,"Persons with condition occurrence of referent concept (31317) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",31317002,31317,referent,
4094294000,17871,Dysphagia or difficulty swallowing design diagnostics 1 cohort,Dysphagia or difficulty swallowing at first diagnosis with 365 days continuous observation. Cohort exit is the end of continuous observable time for the person.,31317003,31317,design diagnostics,
4094294000,17593,Nausea referent incident cohort,"Persons with condition occurrence of referent concept (31967) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",31967001,31967,referent,
4094294000,17592,Nausea referent prevalent cohort,"Persons with condition occurrence of referent concept (31967) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",31967002,31967,referent,
4094294000,18996,Nausea Events All Events of referent concept Nausea + descendants with 30 day gap with >=365d prior observation,Nausea,31967003,31967,,
4094294000,17451,Constipation referent incident cohort,"Persons with condition occurrence of referent concept (75860) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",75860001,75860,referent,
4094294000,17450,Constipation referent prevalent cohort,"Persons with condition occurrence of referent concept (75860) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",75860002,75860,referent,
4094294000,18997,Constipation Events: all occurrence of referent concept + descendants with 30 days gap,Constipation,75860003,75860,,
4094294000,17537,Joint pain referent incident cohort,"Persons with condition occurrence of referent concept (77074) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",77074001,77074,referent,
4094294000,17536,Joint pain referent prevalent cohort,"Persons with condition occurrence of referent concept (77074) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",77074002,77074,referent,
4094294000,17535,Jaundice referent incident cohort,"Persons with condition occurrence of referent concept (137977) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",137977001,137977,referent,
4094294000,17534,Jaundice referent prevalent cohort,"Persons with condition occurrence of referent concept (137977) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",137977002,137977,referent,
4094294000,17551,Low back pain referent incident cohort,"Persons with condition occurrence of referent concept (194133) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",194133001,194133,referent,
4094294000,17550,Low back pain referent prevalent cohort,"Persons with condition occurrence of referent concept (194133) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",194133002,194133,referent,
4094294000,17469,Diarrhea referent incident cohort,"Persons with condition occurrence of referent concept (196523) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",196523001,196523,referent,
4094294000,17468,Diarrhea referent prevalent cohort,"Persons with condition occurrence of referent concept (196523) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",196523002,196523,referent,
4094294000,17841,Diarrhea without bacterial infection design diagnostics 1 cohort,Diarrhea without bacterial infection incident cohort: First occurrence,196523003,196523,design diagnostics,
4094294000,17844,Diarrhea or functional diarrhea design diagnostics 2 cohort,Diarrhea or functional diarrhea incident cohort: First occurrence,196523004,196523,design diagnostics,
4094294000,19002,Diarrhea Events All occurrence of referent concept + descendants,Diarrhea,196523005,196523,,
4094294000,17375,Abdominal pain referent incident cohort,"Persons with condition occurrence of referent concept (200219) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",200219001,200219,referent,
4094294000,17374,Abdominal pain referent prevalent cohort,"Persons with condition occurrence of referent concept (200219) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",200219002,200219,referent,
4094294000,17453,Cough referent incident cohort,"Persons with condition occurrence of referent concept (254761) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",254761001,254761,referent,
4094294000,17452,Cough referent prevalent cohort,"Persons with condition occurrence of referent concept (254761) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",254761002,254761,referent,
4094294000,17722,"Cough prevalent cohort: Episodes of cough, defined by condition occurrences of Cough conceptset",,254761003,254761,,
4094294000,17473,Dyspnea referent incident cohort,"Persons with condition occurrence of referent concept (312437) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",312437001,312437,referent,
4094294000,17472,Dyspnea referent prevalent cohort,"Persons with condition occurrence of referent concept (312437) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",312437002,312437,referent,
4094294000,17725,"Dyspnea prevalent cohort: Episodes of dyspnea, defined by condition occurrences of shortness of breath (dyspnea) conceptset","Episodes of dyspnea, defined by condition occurrences of 'shortness of breath (dyspnea)' conceptset.",312437003,312437,,
4094294000,18687,Paralytic syndrome referent incident cohort,"Persons with condition occurrence of referent concept (374377) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",374377001,374377,referent,
4094294000,18686,Paralytic syndrome referent prevalent cohort,"Persons with condition occurrence of referent concept (374377) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",374377002,374377,referent,
4094294000,17501,Headache referent incident cohort,"Persons with condition occurrence of referent concept (378253) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",378253001,378253,referent,
4094294000,17500,Headache referent prevalent cohort,"Persons with condition occurrence of referent concept (378253) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",378253002,378253,referent,
4094294000,19003,Headache events: All occurrence of referent concept + descendants,Headache,378253003,378253,,
4094294000,17475,Edema referent incident cohort,"Persons with condition occurrence of referent concept (433595) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",433595001,433595,referent,
4094294000,17474,Edema referent prevalent cohort,"Persons with condition occurrence of referent concept (433595) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",433595002,433595,referent,
4094294000,17447,Chronic pain referent incident cohort,"Persons with condition occurrence of referent concept (436096) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",436096001,436096,referent,
4094294000,17446,Chronic pain referent prevalent cohort,"Persons with condition occurrence of referent concept (436096) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",436096002,436096,referent,
4094294000,17818,Taste sense altered referent incident cohort,"Persons with condition occurrence of referent concept (436235) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",436235001,436235,referent,
4094294000,17817,Taste sense altered referent prevalent cohort,"Persons with condition occurrence of referent concept (436235) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",436235002,436235,referent,
4094294000,17533,Insomnia referent incident cohort,"Persons with condition occurrence of referent concept (436962) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",436962001,436962,referent,
4094294000,17532,Insomnia referent prevalent cohort,"Persons with condition occurrence of referent concept (436962) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",436962002,436962,referent,
4094294000,17869,Insomnia design diagnostics 1 cohort,Insomnia with disorders of maintaing sleep (excluding hypo/hypersomnias and sleep walking disorder),436962003,436962,design diagnostics,
4094294000,17870,Insomnia with disorders of maintaing sleep concept plus insomnia medications data diagnostics 1 cohort,Insomnia with disorders of maintaing sleep (excluding hypo/hypersomnias and sleep walking disorder) and medication for insomnia,436962004,436962,data diagnostics,
4094294000,18740,Bleeding referent incident cohort,"Persons with condition occurrence of referent concept (437312) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",437312001,437312,referent,
4094294000,18739,Bleeding referent prevalent cohort,"Persons with condition occurrence of referent concept (437312) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",437312002,437312,referent,
4094294000,18770,"Bleeding, Bleeding during hospitalization",,437312003,437312,,
4094294000,17483,Fever referent incident cohort,"Persons with condition occurrence of referent concept (437663) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",437663001,437663,referent,
4094294000,17482,Fever referent prevalent cohort,"Persons with condition occurrence of referent concept (437663) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",437663002,437663,referent,
4094294000,17721,"Fever prevalent cohort: Episodes of fever, defined by condition occurrences, measurements and observations",,437663003,437663,,
4094294000,18685,Paralysis referent incident cohort,"Persons with condition occurrence of referent concept (440377) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",440377001,440377,referent,
4094294000,18684,Paralysis referent prevalent cohort,"Persons with condition occurrence of referent concept (440377) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",440377002,440377,referent,
4094294000,17713,Vomiting referent incident cohort,"Persons with condition occurrence of referent concept (441408) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",441408001,441408,referent,
4094294000,17712,Vomiting referent prevalent cohort,"Persons with condition occurrence of referent concept (441408) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",441408002,441408,referent,
4094294000,19005,Vomiting Events: All occurrence of referent concept + descendants,Vomiting,441408003,441408,,
4094294000,17407,Anxiety referent incident cohort,"Persons with condition occurrence of referent concept (441542) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",441542001,441542,referent,
4094294000,17406,Anxiety referent prevalent cohort,"Persons with condition occurrence of referent concept (441542) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",441542002,441542,referent,
4094294000,17826,Anxiety referent incident cohort + additional orphan concepts design diagnostics 1 cohort,Anxiety concept set includes concepts from observation domain such as worried,441542003,441542,design diagnostics,
4094294000,17842,Anxiety + additional orphan concepts + 2 OP or 1 IP + drug Data Diagnostics 1,"Anxiety and adjustment disorder with any concepts in observation domain removed such as worried, stupor, ptsd, phobia etc",441542004,441542,data diagnostics,
4094294000,17808,Muscle pain referent incident cohort,"Persons with condition occurrence of referent concept (442752) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",442752001,442752,referent,
4094294000,17807,Muscle pain referent prevalent cohort,"Persons with condition occurrence of referent concept (442752) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",442752002,442752,referent,
4094294000,17723,"Myalgia prevalent cohort: Episodes of myalgia, defined by condition occurrences of myalgia conceptset",,442752003,442752,,
4094294000,17683,Tachycardia referent incident cohort,"Persons with condition occurrence of referent concept (444070) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",444070001,444070,referent,
4094294000,17682,Tachycardia referent prevalent cohort,"Persons with condition occurrence of referent concept (444070) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",444070002,444070,referent,
4094294000,17431,Bradycardia referent incident cohort,"Persons with condition occurrence of referent concept (4169095) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4169095001,4169095,referent,
4094294000,17430,Bradycardia referent prevalent cohort,"Persons with condition occurrence of referent concept (4169095) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4169095002,4169095,referent,
4094294000,17735,"Bradycardia or heart block during hospitalization, defined by conditions, devices and procedures",,4169095003,4169095,,
4094294000,7404,"Bradycardia prevalent cohort, defined by first condition occurrence of Bradycardia with a condition occurrence of Bradycardia anytime after the first event",,4169095004,4169095,,
4094294000,17802,Loss of sense of smell referent incident cohort,"Persons with condition occurrence of referent concept (4185711) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4185711001,4185711,referent,
4094294000,17801,Loss of sense of smell referent prevalent cohort,"Persons with condition occurrence of referent concept (4185711) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4185711002,4185711,referent,
4094294000,18645,Fatigue referent incident cohort,"Persons with condition occurrence of referent concept (4223659) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4223659001,4223659,referent,
4094294000,18644,Fatigue referent prevalent cohort,"Persons with condition occurrence of referent concept (4223659) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4223659002,4223659,referent,
4094294000,17724,"Malaise or fatigue prevalent cohort: Episodes of malaise or fatigue, defined by condition occurrences of Malaise or Fatigue or (Malaise and Fatigue) conceptset","Malaise or fatigue prevalent cohort: Episodes of malaise or fatigue, defined by condition occurrences of 'Malaise or Fatigue or (Malaise and Fatigue)' conceptset",4223659003,4223659,,
4094294000,17553,Malaise referent incident cohort,"Persons with condition occurrence of referent concept (4272240) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4272240001,4272240,referent,
4094294000,17552,Malaise referent prevalent cohort,"Persons with condition occurrence of referent concept (4272240) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4272240002,4272240,referent,
4094294000,17810,Sensory disorder of smell and/or taste referent incident cohort,"Persons with condition occurrence of referent concept (43530714) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",43530714001,43530714,referent,
4094294000,17809,Sensory disorder of smell and/or taste referent prevalent cohort,"Persons with condition occurrence of referent concept (43530714) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",43530714002,43530714,referent,
4094294000,17726,"Anosmia OR Hyposmia OR Dysgeusia episodes, defined by condition occurrences of Altered smell or taste conceptset",,43530714003,43530714,,
4094294000,18627,Cardiac arrhythmia referent incident cohort,"Persons with condition occurrence of referent concept (44784217) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",44784217001,44784217,referent,
4098292000,17405,Antiphospholipid syndrome referent incident cohort,"Persons with condition occurrence of referent concept (4098292) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4098292001,4098292,referent,
4098292000,17404,Antiphospholipid syndrome referent prevalent cohort,"Persons with condition occurrence of referent concept (4098292) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4098292002,4098292,referent,
4112853000,17561,Malignant tumor of breast referent incident cohort,"Persons with condition occurrence of referent concept (4112853) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4112853001,4112853,referent,
4112853000,17560,Malignant tumor of breast referent prevalent cohort,"Persons with condition occurrence of referent concept (4112853) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4112853002,4112853,referent,
4131909000,17597,Neoplasm of thyroid gland referent incident cohort,"Persons with condition occurrence of referent concept (4131909) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4131909001,4131909,referent,
4131909000,17596,Neoplasm of thyroid gland referent prevalent cohort,"Persons with condition occurrence of referent concept (4131909) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4131909002,4131909,referent,
4133004000,17457,Deep venous thrombosis referent incident cohort,"Persons with condition occurrence of referent concept (4133004) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4133004001,4133004,referent,
4133004000,17456,Deep venous thrombosis referent prevalent cohort,"Persons with condition occurrence of referent concept (4133004) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4133004002,4133004,referent,
4133004000,17733,"Deep vein thrombosis events, defined by condition occurrences of Non Cerebral Deep Vein Thrombosis conceptset",,4133004003,4133004,,
4133004000,18939,"Deep vein thrombosis events, defined by condition occurrences of deep vein thrombosis conceptset","Deep vein thrombosis events, defined by condition occurrences of 'Deep vein thrombosis' conceptset",4133004005,4133004,,
4133004000,20078,FDA AESI Deep Vein Thrombosis (DVT) events,All events of Deep Vein Thrombosis with no such events in prior clean window period (365 days). No continuous observation period requirement. Persons exit the cohort on start_date + 1 day.,4133004006,4133004,study;FDA;Covid,
4133004000,20079,FDA AESI Deep Vein Thrombosis (DVT) event episodes for incidence characterization,All events of Deep Vein Thrombosis. No continuous observation period requirement. Persons exit the cohort on start_date + 365 days.,4133004007,4133004,study;FDA;Covid,
4137275000,18651,Granulomatosis with polyangiitis referent incident cohort,"Persons with condition occurrence of referent concept (313223) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",313223001,313223,referent,
4137275000,18650,Granulomatosis with polyangiitis referent prevalent cohort,"Persons with condition occurrence of referent concept (313223) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",313223002,313223,referent,
4137275000,17784,Acute febrile mucocutaneous lymph node syndrome referent incident cohort,"Persons with condition occurrence of referent concept (314381) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",314381001,314381,referent,
4137275000,17783,Acute febrile mucocutaneous lymph node syndrome referent prevalent cohort,"Persons with condition occurrence of referent concept (314381) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",314381002,314381,referent,
4137275000,16234,"Multi-system inflammatory syndrome (Kawasaki disease or toxic shock syndrome) episodes, defined by condition occurrences of Toxic shock syndrome or kawasaki disease conceptset",,314381003,314381,,
4137275000,18510,"Kawasakis disease by Kao, First event of Acute febrile mucocutaneous lymph node syndrome [MCLS",,314381004,314381,literature,
4137275000,18691,Polyarteritis nodosa referent incident cohort,"Persons with condition occurrence of referent concept (320749) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",320749001,320749,referent,
4137275000,18690,Polyarteritis nodosa referent prevalent cohort,"Persons with condition occurrence of referent concept (320749) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",320749002,320749,referent,
4137275000,17425,Behcets syndrome referent incident cohort,"Persons with condition occurrence of referent concept (436642) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",436642001,436642,referent,
4137275000,17424,Behcets syndrome referent prevalent cohort,"Persons with condition occurrence of referent concept (436642) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",436642002,436642,referent,
4137275000,18572,"Behçets syndrome by WU, 2019, earliest event",,436642003,436642,literature,
4137275000,18140,Behcets syndrome design diagnostics 1 cohort,"Behcet's syndrome custom concept (includes arthropathy, ulceration of vulva, penile ulceration)",436642004,436642,design diagnostics,
4137275000,17685,Takayasus disease referent incident cohort,"Persons with condition occurrence of referent concept (440740) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",440740001,440740,referent,
4137275000,17684,Takayasus disease referent prevalent cohort,"Persons with condition occurrence of referent concept (440740) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",440740002,440740,referent,
4137275000,18655,Henoch-Schönlein purpura referent incident cohort,"Persons with condition occurrence of referent concept (4101602) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4101602001,4101602,referent,
4137275000,18654,Henoch-Schönlein purpura referent prevalent cohort,"Persons with condition occurrence of referent concept (4101602) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4101602002,4101602,referent,
4137275000,18509,"Henoch-Schönlein purpura by Lei, 2018. First diagnosis of Henoch-Schönlein purpura (Allergic purpura)",,4101602003,4101602,literature,
4137275000,18577,"Hosptalized Henoch-Schonlein purpura by Yagnik, 2019",,4101602004,4101602,literature,
4137275000,17705,Vasculitis referent incident cohort,"Persons with condition occurrence of referent concept (4137275) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4137275001,4137275,referent,
4137275000,17704,Vasculitis referent prevalent cohort,"Persons with condition occurrence of referent concept (4137275) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4137275002,4137275,referent,
4137275000,18505,"Vasculitis by Bernatsky, First diagnosis of Polyarteritis nodosa and allied conditions with > 2 diagnosis or 1 claim by a rheumatologist",,4137275003,4137275,,
4137275000,18711,Vasculitis of the skin referent incident cohort,"Persons with condition occurrence of referent concept (4182711) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4182711001,4182711,referent,
4137275000,18710,Vasculitis of the skin referent prevalent cohort,"Persons with condition occurrence of referent concept (4182711) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4182711002,4182711,referent,
4137275000,17687,Temporal arteritis referent incident cohort,"Persons with condition occurrence of referent concept (4290976) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4290976001,4290976,referent,
4137275000,17686,Temporal arteritis referent prevalent cohort,"Persons with condition occurrence of referent concept (4290976) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4290976002,4290976,referent,
4137275000,11651,Giant cell arteritis at first diagnosis (no history of giant cell arteritis),Giant cell arteritis at first diagnosis with 365 days continuous observation. Cohort exit is the end of continuous observable time for the person.,4290976003,4290976,,
4137275000,18665,Microscopic polyarteritis nodosa referent incident cohort,"Persons with condition occurrence of referent concept (4344489) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4344489001,4344489,referent,
4137275000,18664,Microscopic polyarteritis nodosa referent prevalent cohort,"Persons with condition occurrence of referent concept (4344489) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4344489002,4344489,referent,
4137275000,18138,Antineutrophil cytoplasmic antibody positive vasculitis referent incident cohort,"Persons with condition occurrence of referent concept (42535714) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",42535714001,42535714,referent,
4137275000,18621,Antineutrophil cytoplasmic antibody positive vasculitis referent prevalent cohort,"Persons with condition occurrence of referent concept (42535714) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",42535714002,42535714,referent,
4137275000,11953,Vasculitis associated with Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis,Custom cohort of persons with vasculitis associated with ANCA,42535714003,42535714,,
4137275000,20090,FDA AESI Kawasaki disease pediatric events,All events of Kawasaki Disease with no such events in prior clean window period (365 days) and restricted to ages of 1 to 5 years. No continuous observation period requirement. Persons exit the cohort on start_date + 1 day.,42535714004,314381,study;FDA;Covid,
4137275000,20091,FDA AESI Kawasaki disease pediatric event episodes for incidence characterization,All events of Kawasaki Disease and restricted to ages of 1 to 5 years. No continuous observation period requirement. Persons exit the cohort on start_date + 365 days.,42535714005,314381,study;FDA;Covid,
4139034000,18659,Immune reconstitution syndrome referent incident cohort,"Persons with condition occurrence of referent concept (4139034) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4139034001,4139034,referent,
4139034000,18658,Immune reconstitution syndrome referent prevalent cohort,"Persons with condition occurrence of referent concept (4139034) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4139034002,4139034,referent,
4163261000,17571,Malignant tumor of prostate referent incident cohort,"Persons with condition occurrence of referent concept (4163261) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4163261001,4163261,referent,
4163261000,17570,Malignant tumor of prostate referent prevalent cohort,"Persons with condition occurrence of referent concept (4163261) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4163261002,4163261,referent,
4163261000,17876,"Malignant tumor of prostate excluding secondary cancers, in males, excluding prior other cancers and HO prostate cancer","Primary prostate cancer at first diagnosis, males only, excluding prior cancer (except non-melanoma skin cancer) and excluding h/o prostate cancer and secondary malignant neoplasm of trunk. Malignant tumor of prostate incident cohort: First occurrence of referent concept + descendants excluding secondary cancers, in males, excluding prior other cancers and H/O prostate cancer with >=365d prior observation",4163261003,4163261,data diagnostics,
4163261000,18851,Prostate Cancer Parlett 1,Prostate Cancer Parlett (2019) 1+ codes not more than 28 days after a prostate biopsy,4163261004,4163261,literature,
4163261000,18852,Prostate Cancer Parlett 2,Prostate Cancer Parlett (2019) 1+ codes not more than 28 days after a prostate biopsy + Testosterone Non-users,4163261005,4163261,literature,
4163261000,18853,Prostate Cancer Parlett 3,Prostate Cancer Parlett (2019) 1+ codes not more than 28 days after a prostate biopsy + Testosterone Users,4163261006,4163261,literature,
4163261000,18854,Prostate Cancer Parlett 4,Prostate Cancer Parlett (2019) 1+ codes not more than 28 days after a prostate biopsy + PDE5i Users,4163261007,4163261,literature,
4164770000,18649,Fishers syndrome referent incident cohort,"Persons with condition occurrence of referent concept (4070552) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4070552001,4070552,referent,
4164770000,18648,Fishers syndrome referent prevalent cohort,"Persons with condition occurrence of referent concept (4070552) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4070552002,4070552,referent,
4164770000,18653,Guillain-Barré syndrome referent incident cohort,"Persons with condition occurrence of referent concept (4164770) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4164770001,4164770,referent,
4164770000,18652,Guillain-Barré syndrome referent prevalent cohort,"Persons with condition occurrence of referent concept (4164770) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4164770002,4164770,referent,
4164770000,18478,"Guillain-Barre syndrome inpatient (Arya et al, ScallenWalter et al, Iqbal et al, Anandan et al, Rasmussen et al. Baxter et al.)",,4164770003,4164770,literature,
4164770000,20054,FDA AESI Guillain Barre syndrome events,All events of GB syndrome (includes Fisher syndrome) with no events in prior clean period (365 days). No continuous observation period requirement. Persons exit the cohort on start_date + 1 day. Note - Acute infective polyneuritis code was used to capture GB syndrome in ICD9CM.,4164770004,4164770,study;FDA;Covid,
4164770000,20057,FDA AESI Guillain Barre syndrome IP primary events,"All primary diagnosis events of GB syndrome (includes Fisher syndrome) limited to overlapping inpatient visit, with no such events in prior clean period (365 days). No continuous observation period requirement. Persons exit the cohort on start_date + 1 day. Note - Acute infective polyneuritis code was used to capture GB syndrome in ICD9CM.",4164770005,4164770,study;FDA;Covid,
4164770000,20058,FDA AESI Guillain Barre syndrome IP primary event episodes for incidence characterization,All primary diagnosis events of GB syndrome (includes Fisher syndrome) limited to overlapping inpatient visit. No continuous observation period requirement. Persons exit the cohort on start_date + 365 days. Note - Acute infective polyneuritis code was used to capture GB syndrome in ICD9CM.,4164770006,4164770,study;FDA;Covid,
4164770000,20059,FDA AESI Guillain Barre syndrome event episodes for incidence characterization,All events of GB syndrome (includes Fisher syndrome) with no events in prior clean period (365 days). No continuous observation period requirement. Persons exit the cohort on start_date + 365 days. Note - Acute infective polyneuritis code was used to capture GB syndrome in ICD9CM.,4164770007,4164770,study;FDA;Covid,
4164770000,20068,FDA AESI Guillain Barre syndrome IP events,"All any diagnosis events of GB syndrome (includes Fisher syndrome) limited to overlapping inpatient visit, with no such events in prior clean period (365 days). No continuous observation period requirement. Persons exit the cohort on start_date + 1 day. Note - Acute infective polyneuritis code was used to capture GB syndrome in ICD9CM.",4164770008,4164770,study;FDA;Covid,
4164770000,20069,FDA AESI Guillain Barre syndrome IP event episodes for incidence characterization,All any diagnosis events of GB syndrome (includes Fisher syndrome) limited to overlapping inpatient visit. No continuous observation period requirement. Persons exit the cohort on start_date + 365 days. Note - Acute infective polyneuritis code was used to capture GB syndrome in ICD9CM.,4164770009,4164770,study;FDA;Covid,
4175485000,17591,Myelofibrosis referent incident cohort,"Persons with condition occurrence of referent concept (133169) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",133169001,133169,referent,
4175485000,17590,Myelofibrosis referent prevalent cohort,"Persons with condition occurrence of referent concept (133169) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",133169002,133169,referent,
4175485000,17589,Myelodysplastic syndrome referent incident cohort,"Persons with condition occurrence of referent concept (138994) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",138994001,138994,referent,
4175485000,17588,Myelodysplastic syndrome referent prevalent cohort,"Persons with condition occurrence of referent concept (138994) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",138994002,138994,referent,
4175485000,17377,Acute myeloid leukemia referent incident cohort,"Persons with condition occurrence of referent concept (140352) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",140352001,140352,referent,
4175485000,17376,Acute myeloid leukemia referent prevalent cohort,"Persons with condition occurrence of referent concept (140352) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",140352002,140352,referent,
4180790000,17565,Malignant tumor of colon referent incident cohort,"Persons with condition occurrence of referent concept (4180790) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4180790001,4180790,referent,
4180790000,17564,Malignant tumor of colon referent prevalent cohort,"Persons with condition occurrence of referent concept (4180790) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4180790002,4180790,referent,
4181343000,17567,Malignant tumor of esophagus referent incident cohort,"Persons with condition occurrence of referent concept (4181343) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4181343001,4181343,referent,
4181343000,17566,Malignant tumor of esophagus referent prevalent cohort,"Persons with condition occurrence of referent concept (4181343) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4181343002,4181343,referent,
4181351000,17569,Malignant tumor of ovary referent incident cohort,"Persons with condition occurrence of referent concept (4181351) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4181351001,4181351,referent,
4181351000,17568,Malignant tumor of ovary referent prevalent cohort,"Persons with condition occurrence of referent concept (4181351) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4181351002,4181351,referent,
4182210000,17461,Dementia referent incident cohort,"Persons with condition occurrence of referent concept (4182210) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4182210001,4182210,referent,
4182210000,17460,Dementia referent prevalent cohort,"Persons with condition occurrence of referent concept (4182210) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4182210002,4182210,referent,
4185932000,17379,Acute myocardial infarction referent incident cohort,"Persons with condition occurrence of referent concept (312327) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",312327001,312327,referent,
4185932000,17378,Acute myocardial infarction referent prevalent cohort,"Persons with condition occurrence of referent concept (312327) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",312327002,312327,referent,
4185932000,17753,"Acute myocardial infarction events, defined by condition occurrences of Acute myocardial Infarction conceptset occurring between start and end of inpatient or ER visit","Episodes of Acute myocardial infarction events, defined by condition occurrences of 'Acute myocardial Infarction' conceptset occurring between start and end of inpatient or ER visit. Exit criteria 7 days after start of index event.",312327003,312327,,
4185932000,18935,"Acute myocardial infarction events, defined by condition occurrences of Acute myocardial Infarction conceptset","Acute myocardial infarction events, defined by condition occurrences of 'Acute myocardial Infarction' conceptset",312327004,312327,,
4185932000,18742,Coronary arteriosclerosis referent incident cohort,"Persons with condition occurrence of referent concept (317576) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",317576001,317576,referent,
4185932000,18741,Coronary arteriosclerosis referent prevalent cohort,"Persons with condition occurrence of referent concept (317576) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",317576002,317576,referent,
4185932000,17401,Angina pectoris referent incident cohort,"Persons with condition occurrence of referent concept (321318) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",321318001,321318,referent,
4185932000,17400,Angina pectoris referent prevalent cohort,"Persons with condition occurrence of referent concept (321318) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",321318002,321318,referent,
4185932000,17744,Chest pain or angina prevalent cohort: First condition occurrence of Chest pain or angina conceptset,The first condition record of chest pain or angina,321318003,321318,,
4185932000,17745,"Angina pectoris during hospitalization, defined by condition occurrences of Angina pectoris conceptset occurring between start and end of inpatient visit","Angina pectoris during hospitalization, defined by condition occurrences of 'Angina pectoris' conceptset occurring between start and end of inpatient visit",321318004,321318,,
4185932000,18661,Ischemic heart disease referent incident cohort,"Persons with condition occurrence of referent concept (4185932) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4185932001,4185932,referent,
4185932000,18660,Ischemic heart disease referent prevalent cohort,"Persons with condition occurrence of referent concept (4185932) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4185932002,4185932,referent,
4185932000,20074,FDA AESI Acute Myocardial Infarction IP events,All events of Acute Myocardial Infarction limited to events with overlapping inpatient stay with no such events in prior clean window period (365 days). No continuous observation period requirement. Persons exit the cohort on start_date + 1 day.,4185932003,312327,study;FDA;Covid,
4185932000,20075,FDA AESI Acute Myocardial Infarction IP event episodes for incidence characterization,All events of Acute Myocardial Infarction limited to events with overlapping inpatient stay. No continuous observation period requirement. Persons exit the cohort on start_date + 365 days.,4185932004,312327,study;FDA;Covid,
4189294000,18675,Myocarditis referent incident cohort,"Persons with condition occurrence of referent concept (314383) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",314383001,314383,referent,
4189294000,18674,Myocarditis referent prevalent cohort,"Persons with condition occurrence of referent concept (314383) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",314383002,314383,referent,
4189294000,18520,"Myocarditis by Sundbøll, First diagnosis of custom codes from Sundbøll, during inpatient or outpatient",,314383003,314383,literature,
4189294000,18579,"Myocarditis by Shah, 2019, hospitalized with primary diagnosis",,314383004,314383,literature,
4189294000,17623,Pericarditis referent incident cohort,"Persons with condition occurrence of referent concept (4138837) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4138837001,4138837,referent,
4189294000,17622,Pericarditis referent prevalent cohort,"Persons with condition occurrence of referent concept (4138837) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4138837002,4138837,referent,
4189294000,18522,Pericarditis by Darmoch,,4138837003,4138837,literature,
4189294000,18557,Pericarditis by Sundbøll,,4138837004,4138837,literature,
4189294000,20076,FDA AESI Myocarditis Pericarditis events,All events of Myocarditis or Pericarditis with no such events in prior clean window period (365 days). No continuous observation period requirement. Persons exit the cohort on start_date + 1 day.,4138837005,4164489,study;FDA;Covid,
4189294000,20077,FDA AESI Myocarditis Pericarditis event episodes for incidence characterization,All events of Myocarditis Pericarditis limited to events with overlapping inpatient stay. No continuous observation period requirement. Persons exit the cohort on start_date + 365 days.,4138837006,4164489,study;FDA;Covid,
4190307000,18618,Acute transverse myelitis referent incident cohort,"Persons with condition occurrence of referent concept (139803) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",139803001,139803,referent,
4190307000,18617,Acute transverse myelitis referent prevalent cohort,"Persons with condition occurrence of referent concept (139803) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",139803002,139803,referent,
4190307000,18536,"Transverse myelitis events, using diagnosis codes from Minegishi MSRD 2019","Transverse myelitis events, using diagnosis codes from Minegishi MSRD 2019",139803003,139803,literature,
4190307000,18537,"Transverse myelitis hospitalization events, using diagnosis codes from Minegishi MSRD 2019","Transverse myelitis hospitalization events, using diagnosis codes from Minegishi MSRD 2019",139803004,139803,literature,
4190307000,18538,"Transverse myelitis events, using diagnosis codes from Marrie MSRD 2018","Transverse myelitis events, using diagnosis codes from Marrie MSRD 2018",139803005,139803,literature,
4190307000,18539,"Transverse myelitis hospitalization events, using diagnosis codes from Rasmussen BMJ 2012","Transverse myelitis hospitalization events, using diagnosis codes from Rasmussen BMJ 2012",139803006,139803,literature,
4190307000,18540,"Transverse myelitis events, using diagnosis codes used across literature","Transverse myelitis events, using diagnosis codes used across literature",139803007,139803,,
4190307000,18616,Acute disseminated encephalomyelitis referent incident cohort,"Persons with condition occurrence of referent concept (374021) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",374021001,374021,referent,
4190307000,18615,Acute disseminated encephalomyelitis referent prevalent cohort,"Persons with condition occurrence of referent concept (374021) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",374021002,374021,referent,
4190307000,18567,"Acute disseminated encephalomyelitis hospitalization events, using diagnosis codes from Minegishi 2019",,374021003,374021,literature,
4190307000,18568,"Acute disseminated encephalomyelitis hospitalization events, using specific Acute disseminated encephalomyelitis code by Langer-Gould, 2011",,374021004,374021,literature,
4190307000,18503,"Acute disseminated encephalomyelitis Events by VanLandingham, Custom code and require an inpatient, primary diagnosis",,374021005,374021,,
4190307000,18639,Encephalitis referent incident cohort,"Persons with condition occurrence of referent concept (378143) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",378143001,378143,referent,
4190307000,18638,Encephalitis referent prevalent cohort,"Persons with condition occurrence of referent concept (378143) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",378143002,378143,referent,
4190307000,18623,Aseptic meningitis referent incident cohort,"Persons with condition occurrence of referent concept (4201096) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4201096001,4201096,referent,
4190307000,18622,Aseptic meningitis referent prevalent cohort,"Persons with condition occurrence of referent concept (4201096) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4201096002,4201096,referent,
4190307000,18506,Aseptic meningitis by Perez-Vilar (specific codes for meningitias excluding encephalitis diagnosis),,4201096003,4201096,literature,
4190307000,20062,FDA AESI Encephalomyelitis IP events,"All events of Encephalomyelitis (includes myelitis, encephalitis and inflammatory CNS disorder without descendants) limited to events with overlapping inpatient visit with no such events in prior clean window period (183 days). No continuous observation period requirement. Persons exit the cohort on start_date + 1 day.",4201096004,373189,study;FDA;Covid,
4190307000,20063,FDA AESI Encephalomyelitis IP event episodes for incidence characterization,"All events of Encephalomyelitis (includes myelitis, encephalitis and inflammatory CNS disorder without descendants) limited to events with overlapping inpatient visit. No continuous observation period requirement. Persons exit the cohort on start_date + 183 days.",4201096005,373189,study;FDA;Covid,
4190307000,20087,FDA AESI Transverse myelitis IP events,All events of Transverse Myelitis with overlapping inpatient visit with no such events in prior clean window period (365 days). No continuous observation period requirement. Persons exit the cohort on start_date + 1 day.,4201096006,443904,study;FDA;Covid,
4190307000,20088,FDA AESI Transverse myelitis IP event episodes for incidence characterization,All events of Transverse Myelitis with overlapping inpatient visit. No continuous observation period requirement. Persons exit the cohort on start_date + 365 days.,4201096007,443904,study;FDA;Covid,
4212540000,17709,Viral hepatitis C referent incident cohort,"Persons with condition occurrence of referent concept (197494) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",197494001,197494,referent,
4212540000,17708,Viral hepatitis C referent prevalent cohort,"Persons with condition occurrence of referent concept (197494) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",197494002,197494,referent,
4212540000,17757,Hepatitis C prevalent cohort: First condition occurrence of Hepatitis C conceptset,,197494003,197494,,
4212540000,17829,"Hepatitis C prevalent cohort: First condition occurrence of Hepatitis C conceptset (with Viral Hepatitis Carrier, Cirrhosis of liver due to chronic hepatitis C)",,197494004,197494,,
4212540000,16848,Cirrhosis with Prior Hepatitis C (1 IP or 2 OP) Replicating Niu using Hepatitis C conceptset (with Viral Hepatitis Carrier),,197494005,197494,,
4212540000,17836,Viral hepatitis C (including non-specific parent concepts) design diagnostics 1 cohort,Viral hepatitis C (including non-specific concepts for viral hepatitis),197494006,197494,design diagnostics,
4212540000,17881,Cirrhosis with Prior Hepatitis C (1 IP and 2 OP) Replicating Niu using Hepatitis C conceptset (with Viral Hepatitis Carrier),,197494007,197494,,
4212540000,18817,Hepatitis C Niu 2,"Viral Hepatitis C Niu (2016) 2+ codes In-patient or 2+ codes out-patient within 365 D of cirrhosis (1+ codes inpatient or 2+ codes outpatient ICD-9-CM codes for cirrhosis: ICD-9-CM-571.2, 571.5)",197494008,197494,literature,25335773
4212540000,18818,Hepatitis C Niu 3,"Viral Hepatitis C Niu (2016) 1+ codes In-patient AND 2+ codes out-patient within 365 D of cirrhosis (1+ codes inpatient or 2+ codes outpatient ICD-9-CM codes for cirrhosis: ICD-9-CM-571.2, 571.5)",197494009,197494,literature,25335773
4212540000,18819,Hepatitis C Re 1,Viral Hepatitis C Re (2009) 1+ codes,197494010,197494,literature,19551699
4212540000,18816,Hepatitis C Niu 1,"Viral Hepatitis C Niu (2016) 1+ codes In-patient or 2+ codes out-patient within 365 D of cirrhosis (1+ codes inpatient or 2+ codes outpatient ICD-9-CM codes for cirrhosis: ICD-9-CM-571.2, 571.5)",197494011,197494,literature,25335773
4212540000,17421,Autoimmune hepatitis referent incident cohort,"Persons with condition occurrence of referent concept (200762) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",200762001,200762,referent,
4212540000,17420,Autoimmune hepatitis referent prevalent cohort,"Persons with condition occurrence of referent concept (200762) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",200762002,200762,referent,
4212540000,17059,Autoimmune Hepatitis incidence cohort including non standard code of autoimmune chronic active hepatitis,Autoimmune Hepatitis (or non standard codes) at first diagnosis with 365 days continuous observation. Cohort exit is the end of continuous observable time for the person.,200762003,200762,,
4212540000,16903,Autoimmune Hepatitis incident cohort with a second diagnosis within 12 month after index date,Autoimmune Hepatitis incident disease with a second diagnosis within 12 month after index date,200762004,200762,,
4212540000,16904,Autoimmune Hepatitis incident cohort with a second diagnosis within 24 month after index date,Autoimmune Hepatitis incident disease with a second diagnosis within 24 month after index date,200762005,200762,,
4212540000,18339,Primary sclerosing cholangitis referent incident cohort,"Persons with condition occurrence of referent concept (4058821) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4058821001,4058821,referent,
4212540000,18340,Primary sclerosing cholangitis referent prevalent cohort,"Persons with condition occurrence of referent concept (4058821) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4058821002,4058821,referent,
4212540000,16905,Primary sclerosing cholangitis incidence cohort with atleast one more diagnosis in the 12 months after initial diagnosis,Primary sclerosing cholangitis at first diagnosis with 365 days continuous observation. Cohort exit is the end of continuous observable time for the person.,4058821003,4058821,,
4212540000,16906,Primary sclerosing cholangitis incidence cohort with atleast one more diagnosis in the 24 months after initial diagnosis,Primary sclerosing cholangitis at first diagnosis with 365 days continuous observation. Cohort exit is the end of continuous observable time for the person.,4058821004,4058821,,
4212540000,17092,Primary sclerosing cholangitis excluding sclerosing cholangitis and secondary cholangitis,Primary sclerosing cholangitis excluding sclerosing cholangitis and secondary cholangitis,4058821005,4058821,,
4212540000,17449,Cirrhosis of liver referent incident cohort,"Persons with condition occurrence of referent concept (4064161) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4064161001,4064161,referent,
4212540000,17448,Cirrhosis of liver referent prevalent cohort,"Persons with condition occurrence of referent concept (4064161) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4064161002,4064161,referent,
4212540000,17697,Type B viral hepatitis referent incident cohort,"Persons with condition occurrence of referent concept (4281232) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4281232001,4281232,referent,
4212540000,17696,Type B viral hepatitis referent prevalent cohort,"Persons with condition occurrence of referent concept (4281232) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4281232002,4281232,referent,
4212540000,18855,Hepatitis B Niu 1,"Viral Hepatitis B Niu (2016) 1+ codes In-patient or 2+ codes out-patient within 365 D of cirrhosis (1+ codes inpatient or 2+ codes outpatient ICD-9-CM codes for cirrhosis: ICD-9-CM-571.2, 571.5)",4281232003,4281232,literature,25335773
4212540000,18856,Hepatitis B Niu 2,"Viral Hepatitis B Niu (2016) 2+ codes In-patient or 2+ codes out-patient within 365 D of cirrhosis (1+ codes inpatient or 2+ codes outpatient ICD-9-CM codes for cirrhosis: ICD-9-CM-571.2, 571.5)",4281232004,4281232,literature,25335773
4212540000,18857,Hepatitis B Niu 3,"Viral Hepatitis B Niu (2016) 1+ codes In-patient AND 2+ codes out-patient within 365 D of cirrhosis (1+ codes inpatient or 2+ codes outpatient ICD-9-CM codes for cirrhosis: ICD-9-CM-571.2, 571.5)",4281232005,4281232,literature,25335773
4236484000,18689,Paresthesia referent incident cohort,"Persons with condition occurrence of referent concept (4236484) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4236484001,4236484,referent,
4236484000,18688,Paresthesia referent prevalent cohort,"Persons with condition occurrence of referent concept (4236484) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4236484002,4236484,referent,
4245975000,17507,Hepatic failure referent incident cohort,"Persons with condition occurrence of referent concept (4245975) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4245975001,4245975,referent,
4245975000,17506,Hepatic failure referent prevalent cohort,"Persons with condition occurrence of referent concept (4245975) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4245975002,4245975,referent,
4245975000,14858,"Hepatic failure prevalent cohort: First condition occurrence of hepatic failure, necrosis or coma conceptset","The first condition record of hepatic failure, necrosis, or coma",4245975003,4245975,,
4246127000,17559,Malignant neoplasm of liver referent incident cohort,"Persons with condition occurrence of referent concept (4246127) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4246127001,4246127,referent,
4246127000,17558,Malignant neoplasm of liver referent prevalent cohort,"Persons with condition occurrence of referent concept (4246127) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4246127002,4246127,referent,
4256228000,17385,Acute respiratory failure referent incident cohort,"Persons with condition occurrence of referent concept (319049) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",319049001,319049,referent,
4256228000,17384,Acute respiratory failure referent prevalent cohort,"Persons with condition occurrence of referent concept (319049) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",319049002,319049,referent,
4256228000,18940,Acute respiratory failure design diagnostics 1 cohort,"Respiratory failure, arrest, hypoxemic respiratory failure, hypercapnic respiratory failure (with no descendants) added to acute respiratory failure with descendants",319049003,319049,design diagnostics,
4256228000,17655,Respiratory failure referent incident cohort,"Persons with condition occurrence of referent concept (4256228) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4256228001,4256228,referent,
4256228000,17654,Respiratory failure referent prevalent cohort,"Persons with condition occurrence of referent concept (4256228) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4256228002,4256228,referent,
4266367000,17531,Influenza referent incident cohort,"Persons with condition occurrence of referent concept (4266367) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4266367001,4266367,referent,
4266367000,17530,Influenza referent prevalent cohort,"Persons with condition occurrence of referent concept (4266367) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4266367002,4266367,referent,
4266367000,18765,Influenza custom cohort: Flu-like symptom episodes,,4266367003,4266367,,
4266367000,18766,Influenza: Persons hospitalized with influenza diagnosis or positive test and requiring intensive services 2017-2018,,4266367004,4266367,,
4266367000,18767,Influenza: Persons hospitalized with influenza diagnosis or positive test 2017-2018,,4266367005,4266367,,
4266367000,18768,Influenza: Persons with Influenza diagnosis or positive test 2017-2018,,4266367006,4266367,,
4273391000,17814,Suicidal thoughts referent incident cohort,"Persons with condition occurrence of referent concept (4273391) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4273391001,4273391,referent,
4273391000,17813,Suicidal thoughts referent prevalent cohort,"Persons with condition occurrence of referent concept (4273391) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4273391002,4273391,referent,
4273391000,16525,Suicide and suicidal ideation prevalent cohort: First condition occurrence or observatio of Suicide and suicidal ideation conceptset,,4273391003,4273391,,
4285717000,18756,SLE glomerulonephritis syndrome referent incident cohort,"Persons with condition occurrence of referent concept (4285717) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4285717001,4285717,referent,
4285717000,18755,SLE glomerulonephritis syndrome referent prevalent cohort,"Persons with condition occurrence of referent concept (4285717) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4285717002,4285717,referent,
4285717000,11977,Nephrosis co-occurrent and due to systemic lupus erythematosus or Nephritis with Lupus erythematosus before at first diagnosis,'Nephrosis co-occurrent and due to systemic lupus erythematosus' or 'Nephritis with Lupus erythematosus before' at first diagnosis,4285717003,4285717,,
4285717000,17172,Nephrosis co-occurrent and due to systemic lupus erythematosus at first diagnosis,'Nephrosis co-occurrent and due to systemic lupus erythematosus' at first diagnosis,4285717004,4285717,,
4286201000,17667,Schizoaffective disorder referent incident cohort,"Persons with condition occurrence of referent concept (4286201) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4286201001,4286201,referent,
4286201000,17666,Schizoaffective disorder referent prevalent cohort,"Persons with condition occurrence of referent concept (4286201) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4286201002,4286201,referent,
4299535000,18748,Pregnant referent incident cohort,"Persons with condition occurrence of referent concept (4299535) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4299535001,4299535,referent,
4299535000,18747,Pregnant referent prevalent cohort,"Persons with condition occurrence of referent concept (4299535) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4299535002,4299535,referent,
43021226000,17413,Atopic dermatitis referent incident cohort,"Persons with condition occurrence of referent concept (133834) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",133834001,133834,referent,
43021226000,17412,Atopic dermatitis referent prevalent cohort,"Persons with condition occurrence of referent concept (133834) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",133834002,133834,referent,
43021226000,12800,"Atopic dermatitis (with exclusions of flexural, besniers, neuroderamatitis from concept set) at first diagnosis",Atopic dermatitis (has exclusions in concept set) at first diagnosis with 365 days continuous observation. Cohort exit is the end of continuous observable time for the person.,133834003,133834,,
43021226000,17143,Atopic dermatitis and Eczema at first diagnosis,Atopic dermatitis and Eczema at first diagnosis with 365 days continous observation. Cohort exist is the end of continuous observation time for the person.,133834005,133834,,
43021226000,18858,Atopic Dermatitis Hsu 1,Atopic dermatitis Hsu (2017) 1+ codes,133834006,133834,literature,27997983
43021226000,18859,Atopic Dermatitis Hsu 2,Atopic dermatitis Hsu (2017) 2+ codes,133834007,133834,literature,27997983
43021226000,18860,Atopic Dermatitis Hsu 3,Atopic dermatitis Hsu (2017) 2+ codes Plus hay fever and/or asthma,133834008,133834,literature,27997983
43021226000,18861,Atopic Dermatitis Hsu 4,Atopic dermatitis Hsu (2017) 2+ codes Plus hay fever or asthma and food allergy,133834009,133834,literature,27997983
43021226000,18862,Atopic Dermatitis Hsu 5,Atopic dermatitis Hsu (2017) 1+ codes,133834010,133834,literature,27997983
43021226000,18863,Atopic Dermatitis Hsu 6,Atopic dermatitis Hsu (2017) 2+ codes,133834011,133834,literature,27997983
43021226000,18864,Atopic Dermatitis Hsu 7,Atopic dermatitis Hsu (2017) 2+ codes Plus hay fever and/or asthma,133834012,133834,literature,27997983
43021226000,18865,Atopic Dermatitis Hsu 8,"Atopic dermatitis Hsu (2017) 2+ codes Plus hay fever, food allergy, and/or asthma",133834013,133834,literature,27997983
43021226000,17391,Allergic rhinitis referent incident cohort,"Persons with condition occurrence of referent concept (257007) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",257007001,257007,referent,
43021226000,17390,Allergic rhinitis referent prevalent cohort,"Persons with condition occurrence of referent concept (257007) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",257007002,257007,referent,
43021226000,17411,Asthma referent incident cohort,"Persons with condition occurrence of referent concept (317009) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",317009001,317009,referent,
43021226000,17410,Asthma referent prevalent cohort,"Persons with condition occurrence of referent concept (317009) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",317009002,317009,referent,
43021226000,17741,"Hospitalization for Asthma, defined by inpatient visit with a primary condition occurrence of asthma conceptset","Hospitalization for Asthma, defined by inpatient visit with at least 1 condition occurrence of 'asthma' conceptset with type indicating '1st' or 'primary' condition occurring between start and end of inpatient or inpatient/ER visit. Cohort exit is at inpatient visit end date.",317009003,317009,,
43021226000,17767,"Asthma prevalent cohort, defined by condition occurrence or observation of asthma or drug exposure for asthma therapy at age<55 with a second asthma therapy in the 365d to 180d before entry event, and no prior condition of COPD","Persons with asthma, defined by condition occurrence or observation of 'asthma' or drug exposure for 'asthma therapy' at age<55 with a second 'asthma therapy' in the 365d to 180d before entry event, and no condition of 'COPD' or drug exposure of 'LAMA' anytime on or before entry event. Persons exit cohort at end of observation period.",317009004,317009,,
43021226000,17768,"Asthma or COPD prevalent cohort, defined by condition occurrence of asthma or chronic obstructive lung disease or drug exposure for respiratory therapy with a second respiratory therapy in the 180d to 365d after entry event","Persons with Asthma or COPD, defined by earliest of condition occurrence of 'asthma' or 'chronic obstructive lung disease' or drug exposure for 'respiratory therapy' with a second drug exposure of 'respiratory therapy' in the 180d to 365d after entry event. Persons exit cohort at end of observation period.",317009005,317009,,
43021226000,18775,Prevalent Asthma without COPD,,317009006,317009,,
43021226000,17786,Angioedema referent incident cohort,"Persons with condition occurrence of referent concept (432791) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",432791001,432791,referent,
43021226000,17785,Angioedema referent prevalent cohort,"Persons with condition occurrence of referent concept (432791) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",432791002,432791,referent,
43021226000,7377,"Angioedema events, defined by condition occurrences of Angioedema conceptset occurring between start and end of inpatient or ER visit",,432791003,432791,,
43021226000,18620,Anaphylaxis referent incident cohort,"Persons with condition occurrence of referent concept (441202) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",441202001,441202,referent,
43021226000,18619,Anaphylaxis referent prevalent cohort,"Persons with condition occurrence of referent concept (441202) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",441202002,441202,referent,
43021226000,18487,Anaphylactic reaction by Walsh (Mini-sentinial validated definition),,441202003,441202,literature,
43021226000,18602,Anaphylactic reaction by Mesfin,"ICD-10: T80.5, T80.6, T88.1 ED encounters",441202004,441202,literature,
43021226000,20053,FDA AESI Anaphylaxis events,All events of anaphylaxis (not including food anaphylaxis) with no such events in prior clean window period (30 days). No continuous observation period requirement. Persons exit the cohort on start_date + 1 day.,441202005,441202,study;FDA;Covid,
43021226000,20056,FDA AESI Anaphylaxis events for incidence characterization,All events of anaphylaxis (not including food anaphylaxis). No continuous observation period requirement. Persons exit the cohort on start_date + 30 days.,441202006,441202,study;FDA;Covid,
4306655000,18679,Newborn death referent incident cohort,"Persons with condition occurrence of referent concept (4079843) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4079843001,4079843,referent,
4306655000,18678,Newborn death referent prevalent cohort,"Persons with condition occurrence of referent concept (4079843) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4079843002,4079843,referent,
4306655000,17792,Death referent incident cohort,"Persons with condition occurrence of referent concept (4306655) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4306655001,4306655,referent,
4306655000,17791,Death referent prevalent cohort,"Persons with condition occurrence of referent concept (4306655) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4306655002,4306655,referent,
4306655000,17823,"Death events, defined by earliest of observation of Death conceptset or death record",,4306655003,4306655,,
4306655000,17824,"Cardiovascular-related mortality events, defined by earliest of observation of Death conceptset or death record, with condition occurrence of cardiovascular disease during the 30d before through 7d after death",,4306655004,4306655,,
4311499000,17635,Primary malignant neoplasm of respiratory tract referent incident cohort,"Persons with condition occurrence of referent concept (4311499) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4311499001,4311499,referent,
4311499000,17634,Primary malignant neoplasm of respiratory tract referent prevalent cohort,"Persons with condition occurrence of referent concept (4311499) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4311499002,4311499,referent,
4322024000,17647,Pulmonary hypertension referent incident cohort,"Persons with condition occurrence of referent concept (4322024) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4322024001,4322024,referent,
4322024000,17646,Pulmonary hypertension referent prevalent cohort,"Persons with condition occurrence of referent concept (4322024) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4322024002,4322024,referent,
432571000,17423,B-cell lymphoma referent incident cohort,"Persons with condition occurrence of referent concept (434592) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",434592001,434592,referent,
432571000,17422,B-cell lymphoma referent prevalent cohort,"Persons with condition occurrence of referent concept (434592) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",434592002,434592,referent,
432571000,17845,B-cell lymphoma design diagnostics 1 cohort,"B-cell lymphoma (excluding plasmacytoma, b-cell chronic lymphocytic leukemia, including macroglobulinemia)",434592003,434592,design diagnostics,
432571000,17599,Non-Hodgkins lymphoma referent incident cohort,"Persons with condition occurrence of referent concept (4038838) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4038838001,4038838,referent,
432571000,17598,Non-Hodgkins lymphoma referent prevalent cohort,"Persons with condition occurrence of referent concept (4038838) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4038838002,4038838,referent,
432571000,17485,Follicular non-Hodgkins lymphoma referent incident cohort,"Persons with condition occurrence of referent concept (4147411) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4147411001,4147411,referent,
432571000,17484,Follicular non-Hodgkins lymphoma referent prevalent cohort,"Persons with condition occurrence of referent concept (4147411) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4147411002,4147411,referent,
432571000,17577,Mantle cell lymphoma referent incident cohort,"Persons with condition occurrence of referent concept (40481901) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",40481901001,40481901,referent,
432571000,17576,Mantle cell lymphoma referent prevalent cohort,"Persons with condition occurrence of referent concept (40481901) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",40481901002,40481901,referent,
432571000,17579,Marginal zone lymphoma referent incident cohort,"Persons with condition occurrence of referent concept (40490918) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",40490918001,40490918,referent,
432571000,17578,Marginal zone lymphoma referent prevalent cohort,"Persons with condition occurrence of referent concept (40490918) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",40490918002,40490918,referent,
432585000,18625,Blood coagulation disorder referent incident cohort,"Persons with condition occurrence of referent concept (432585) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",432585001,432585,referent,
432585000,18624,Blood coagulation disorder referent prevalent cohort,"Persons with condition occurrence of referent concept (432585) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",432585002,432585,referent,
432585000,20083,FDA AESI Disseminated intravascular coagulation IP events,All events of Disseminated Intravascular Coagulation with overlapping inpatient visit with no such events in prior clean window period (365 days). No continuous observation period requirement. Persons exit the cohort on start_date + 1 day.,432585003,436093,study;FDA;Covid,
432585000,20084,FDA AESI Disseminated intravascular coagulation IP event episodes for incidence characterization,All events of Disseminated Intravascular Coagulation with overlapping inpatient visit. No continuous observation period requirement. Persons exit the cohort on start_date + 365 days.,432585004,436093,study;FDA;Covid,
432595000,17397,Amyloidosis referent incident cohort,"Persons with condition occurrence of referent concept (432595) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",432595001,432595,referent,
432595000,17396,Amyloidosis referent prevalent cohort,"Persons with condition occurrence of referent concept (432595) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",432595002,432595,referent,
432867000,17519,Hyperlipidemia referent incident cohort,"Persons with condition occurrence of referent concept (432867) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",432867001,432867,referent,
432867000,17518,Hyperlipidemia referent prevalent cohort,"Persons with condition occurrence of referent concept (432867) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",432867002,432867,referent,
433736000,17601,Obesity referent incident cohort,"Persons with condition occurrence of referent concept (433736) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",433736001,433736,referent,
433736000,17600,Obesity referent prevalent cohort,"Persons with condition occurrence of referent concept (433736) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",433736002,433736,referent,
433736000,17763,Obesity prevalent cohort: Earliest of condition occurrence or observation of obesity diagnoses conceptset or BMI > 30 or body weight > 120kg,"assumes that once observed to be obese, that state continues until end of observation",433736003,433736,,
434119000,17511,Hidradenitis referent incident cohort,"Persons with condition occurrence of referent concept (434119) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",434119001,434119,referent,
434119000,17510,Hidradenitis referent prevalent cohort,"Persons with condition occurrence of referent concept (434119) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",434119002,434119,referent,
434119000,17146,Hidradenitis at first diagnosis,Hidradenitis at first diagnosis with 365 days continuous observation. Cohort exit is the end of continuous observable time for the person.,434119003,434119,,
434557000,17691,Tuberculosis referent incident cohort,"Persons with condition occurrence of referent concept (434557) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",434557001,434557,referent,
434557000,17690,Tuberculosis referent prevalent cohort,"Persons with condition occurrence of referent concept (434557) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",434557002,434557,referent,
434557000,17719,Tuberculosis prevalent cohort: First condition occurrence of Respiratory and pulmonary tuberculosis conceptset,,434557003,434557,,
434557000,17765,Tuberculosis prevalent cohort: Condition occurrence of Respiratory and pulmonary tuberculosis conceptset with at least 3 distinct drug eras of tuberculosis drugs,,434557004,434557,,
434584000,17541,Kaposis sarcoma referent incident cohort,"Persons with condition occurrence of referent concept (434584) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",434584001,434584,referent,
434584000,17540,Kaposis sarcoma referent prevalent cohort,"Persons with condition occurrence of referent concept (434584) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",434584002,434584,referent,
434610000,17517,Hyperkalemia referent incident cohort,"Persons with condition occurrence of referent concept (434610) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",434610001,434610,referent,
434610000,17516,Hyperkalemia referent prevalent cohort,"Persons with condition occurrence of referent concept (434610) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",434610002,434610,referent,
435783000,17669,Schizophrenia referent incident cohort,"Persons with condition occurrence of referent concept (435783) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",435783001,435783,referent,
435783000,17668,Schizophrenia referent prevalent cohort,"Persons with condition occurrence of referent concept (435783) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",435783002,435783,referent,
435783000,18990,"Schizophrenia by Ren, 2005 and repeated in literature",Schizophrenia concept set occurring two times within 365 days or 1 inpatient diagnosis/ER visit on the day of diagnosis. Paraphrenia is not included,435783003,435783,literature,
435783000,18991,"Schizophrenia by Lai, E. C. et al. 2014",Schizophrenia concept set not including Paraphrenia and an anti-psychotic within 90 days,435783004,435783,literature,
436073000,17641,Psychotic disorder referent incident cohort,"Persons with condition occurrence of referent concept (436073) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",436073001,436073,referent,
436073000,17640,Psychotic disorder referent prevalent cohort,"Persons with condition occurrence of referent concept (436073) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",436073002,436073,referent,
436073000,16526,"Hospitalization for Psychosis, defined by inpatient visit with a primary condition occurrence of psychosis conceptset",,436073003,436073,,
436081000,17585,Multiple myeloma referent incident cohort,"Persons with condition occurrence of referent concept (437233) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",437233001,437233,referent,
436081000,17584,Multiple myeloma referent prevalent cohort,"Persons with condition occurrence of referent concept (437233) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",437233002,437233,referent,
436081000,18838,Multiple Myeloma Brandenburg 1,Multiple Myeloma Brandenburg (2019) 2+ codes at least 30days apart,437233003,437233,literature,30719785
436081000,18839,Multiple Myeloma Brandenburg 2,Multiple Myeloma Brandenburg (2019) Algorithm 2 (see paper),437233004,437233,literature,30719785
436081000,18840,Multiple Myeloma Brandenburg 3,Multiple Myeloma Brandenburg (2019) Algorithm 3 (see paper),437233005,437233,literature,30719785
436081000,18841,Multiple Myeloma Brandenburg 4,Multiple Myeloma Brandenburg (2019) Algorithm 4 (see paper),437233006,437233,literature,30719785
436081000,18667,Monoclonal gammopathy referent incident cohort,"Persons with condition occurrence of referent concept (4002359) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4002359001,4002359,referent,
436081000,18666,Monoclonal gammopathy referent prevalent cohort,"Persons with condition occurrence of referent concept (4002359) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4002359002,4002359,referent,
436081000,17715,Waldenström macroglobulinemia referent incident cohort,"Persons with condition occurrence of referent concept (4098597) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4098597001,4098597,referent,
436081000,17714,Waldenström macroglobulinemia referent prevalent cohort,"Persons with condition occurrence of referent concept (4098597) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4098597002,4098597,referent,
436100000,18677,Narcolepsy referent incident cohort,"Persons with condition occurrence of referent concept (436100) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",436100001,436100,referent,
436100000,18676,Narcolepsy referent prevalent cohort,"Persons with condition occurrence of referent concept (436100) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",436100002,436100,referent,
436100000,18574,Narcolepsy (generalized algorithm from literature),,436100003,436100,,
436100000,20064,FDA AESI Narcolepsy events,All events of Narcolepsy (includes cataplexy with narcolepsy) with no such events in prior clean window period (365 days). No continuous observation period requirement. Persons exit the cohort on start_date + 1 day.,436100004,436100,study;FDA;Covid,
436100000,20065,FDA AESI Narcolepsy event episodes for incidence characterization,All events of Narcolepsy (includes cataplexy with narcolepsy). No continuous observation period requirement. Persons exit the cohort on start_date + 365 days.,436100005,436100,study;FDA;Covid,
436665000,17429,Bipolar disorder referent incident cohort,"Persons with condition occurrence of referent concept (436665) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",436665001,436665,referent,
436665000,17428,Bipolar disorder referent prevalent cohort,"Persons with condition occurrence of referent concept (436665) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",436665002,436665,referent,
436665000,18867,Bipolar Disorder Castro 1,Bipolar Castro (2015) coded-Strict (see paper),436665003,436665,literature,
436665000,18868,Bipolar Disorder Castro 2,Bipolar Castro (2015) coded-Broad 1 (see paper),436665004,436665,literature,
436665000,18869,Bipolar Disorder Castro 3,Bipolar Castro (2015) coded-Broad 2 (see paper),436665005,436665,literature,
436676000,17631,Posttraumatic stress disorder referent incident cohort,"Persons with condition occurrence of referent concept (436676) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",436676001,436676,referent,
436676000,17630,Posttraumatic stress disorder referent prevalent cohort,"Persons with condition occurrence of referent concept (436676) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",436676002,436676,referent,
437222000,17657,Respiratory syncytial virus infection referent incident cohort,"Persons with condition occurrence of referent concept (437222) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",437222001,437222,referent,
437222000,17656,Respiratory syncytial virus infection referent prevalent cohort,"Persons with condition occurrence of referent concept (437222) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",437222002,437222,referent,
437222000,17998,Respiratory syncytial virus infection prevalent cohort during a hospitalization,,437222003,437222,,
437222000,18333,Respiratory syncytial virus infection hospitalization with an RSV test w/in 7 days,,437222004,437222,,
437222000,18334,Respiratory syncytial virus infection with an RSV test w/in 7 days,,437222005,437222,,
437222000,18332,Respiratory syncytial virus infection and (Hospitalized OR RSV Test w/in 7 Days OR 2nd DX w/in 7 days),,437222006,437222,,
437541000,17495,Glaucoma referent incident cohort,"Persons with condition occurrence of referent concept (437541) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",437541001,437541,referent,
437541000,17494,Glaucoma referent prevalent cohort,"Persons with condition occurrence of referent concept (437541) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",437541002,437541,referent,
437833000,17525,Hypokalemia referent incident cohort,"Persons with condition occurrence of referent concept (437833) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",437833001,437833,referent,
437833000,17524,Hypokalemia referent prevalent cohort,"Persons with condition occurrence of referent concept (437833) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",437833002,437833,referent,
438120000,17607,Opioid dependence referent incident cohort,"Persons with condition occurrence of referent concept (438120) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",438120001,438120,referent,
438120000,17606,Opioid dependence referent prevalent cohort,"Persons with condition occurrence of referent concept (438120) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",438120002,438120,referent,
438130000,17605,Opioid abuse referent incident cohort,"Persons with condition occurrence of referent concept (438130) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",438130001,438130,referent,
438130000,17604,Opioid abuse referent prevalent cohort,"Persons with condition occurrence of referent concept (438130) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",438130002,438130,referent,
438409000,17417,Attention deficit hyperactivity disorder referent incident cohort,"Persons with condition occurrence of referent concept (438409) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",438409001,438409,referent,
438409000,17416,Attention deficit hyperactivity disorder referent prevalent cohort,"Persons with condition occurrence of referent concept (438409) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",438409002,438409,referent,
439393000,18693,Pre-eclampsia referent incident cohort,"Persons with condition occurrence of referent concept (439393) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",439393001,439393,referent,
439393000,18692,Pre-eclampsia referent prevalent cohort,"Persons with condition occurrence of referent concept (439393) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",439393002,439393,referent,
439727000,17513,Human immunodeficiency virus infection referent incident cohort,"Persons with condition occurrence of referent concept (439727) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",439727001,439727,referent,
439727000,17512,Human immunodeficiency virus infection referent prevalent cohort,"Persons with condition occurrence of referent concept (439727) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",439727002,439727,referent,
439727000,17716,HIV excluding HIV-II design diagnostics 1 cohort,"Excludes HIV II, and HIV negative. Has finding of HIV status which may indicate positive",439727004,439727,design diagnostics,
439776000,17419,Autism spectrum disorder referent incident cohort,"Persons with condition occurrence of referent concept (439776) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",439776001,439776,referent,
439776000,17418,Autism spectrum disorder referent prevalent cohort,"Persons with condition occurrence of referent concept (439776) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",439776002,439776,referent,
439776000,18880,Autism Burke 1,Autism Burke (2014) 1+ codes complex,439776003,439776,literature,
439776000,18881,Autism Burke 2,Autism Burke (2014) 2+ codes complex,439776004,439776,literature,
440383000,17463,Depressive disorder referent incident cohort,"Persons with condition occurrence of referent concept (440383) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",440383001,440383,referent,
440383000,17462,Depressive disorder referent prevalent cohort,"Persons with condition occurrence of referent concept (440383) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",440383002,440383,referent,
440383000,16527,"Depressive disorder prevalent cohort, defined as the earliest condition occurrence of Depressive disorder conceptset with no treatment more than 30 days prior and no prior psychosies/mania",,440383003,440383,,
440383000,17875,Depressive disorder without bipolar design diagnostics 1 cohort,"Depressive disorder, excludes schizoaffective, reactive depressive psychosis, chronic depressive personality disorder, bipolar and atypical depressive disorder",440383004,440383,design diagnostics,
440417000,17645,Pulmonary embolism referent incident cohort,"Persons with condition occurrence of referent concept (440417) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",440417001,440417,referent,
440417000,17644,Pulmonary embolism referent prevalent cohort,"Persons with condition occurrence of referent concept (440417) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",440417002,440417,referent,
440417000,17732,"Pulmonary embolism events, defined by condition occurrences of Pulmonary embolism conceptset",,440417003,440417,,
440417000,17858,"Pulmonary embolism (including obstetric PEs, exclude personal history) design diagnostics 1 cohort","Pulmonary embolism (including obstetric PEs), Excludes history of pulmonary embolism",440417004,440417,design diagnostics,
440417000,17857,"Pulmonary embolism (excluding obstetric PEs, exclude personal history) design diagnostics 2 cohort","Pulmonary embolism (excluding obstetric PEs), Excludes history of pulmonary embolism",440417005,440417,design diagnostics,
440417000,18842,Pulmonary Embolism Alotaibi 1,"Pulmonary Embolism Alotaibi (2015) 1+ codes, in-patient",440417006,440417,literature,25834115
440417000,18843,Pulmonary Embolism Alotaibi 2,"Pulmonary Embolism Alotaibi (2015) 1+ codes, in-patient, first position",440417007,440417,literature,25834115
440417000,18844,Pulmonary Embolism White 1,"Pulmonary Embolism White (2010) 1+ codes In-patient, Primary position",440417008,440417,literature,20430419
440417000,18845,Pulmonary Embolism White 2,"Pulmonary Embolism White (2010) 1+ codes In-patient, Secondary position",440417009,440417,literature,20430419
440417000,20080,FDA AESI Pulmonary embolism events,All events of Pulmonary Embolism with no such events in prior clean window period (365 days). No continuous observation period requirement. Persons exit the cohort on start_date + 1 day.,440417010,440417,study;FDA;Covid,
440417000,20082,FDA AESI Pulmonary embolism event episodes for incidence characterization,All events of Pulmonary Embolism. No continuous observation period requirement. Persons exit the cohort on start_date + 365 days.,440417011,440417,study;FDA;Covid,
440674000,17497,Gout referent incident cohort,"Persons with condition occurrence of referent concept (440674) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",440674001,440674,referent,
440674000,17496,Gout referent prevalent cohort,"Persons with condition occurrence of referent concept (440674) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",440674002,440674,referent,
440925000,17816,Suicide referent incident cohort,"Persons with condition occurrence of referent concept (440925) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",440925001,440925,referent,
440925000,17815,Suicide referent prevalent cohort,"Persons with condition occurrence of referent concept (440925) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",440925002,440925,referent,
440940000,17581,Methicillin resistant Staphylococcus aureus infection referent incident cohort,"Persons with condition occurrence of referent concept (440940) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",440940001,440940,referent,
440940000,17580,Methicillin resistant Staphylococcus aureus infection referent prevalent cohort,"Persons with condition occurrence of referent concept (440940) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",440940002,440940,referent,
441284000,17603,Open-angle glaucoma referent incident cohort,"Persons with condition occurrence of referent concept (441284) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",441284001,441284,referent,
441284000,17602,Open-angle glaucoma referent prevalent cohort,"Persons with condition occurrence of referent concept (441284) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",441284002,441284,referent,
441788000,17515,Human papilloma virus infection referent incident cohort,"Persons with condition occurrence of referent concept (441788) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",441788001,441788,referent,
441788000,17514,Human papilloma virus infection referent prevalent cohort,"Persons with condition occurrence of referent concept (441788) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",441788002,441788,referent,
443213000,17812,Stillbirth referent incident cohort,"Persons with condition occurrence of referent concept (443213) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",443213001,443213,referent,
443213000,17811,Stillbirth referent prevalent cohort,"Persons with condition occurrence of referent concept (443213) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",443213002,443213,referent,
443213000,17738,"Stillbirth events, defined by condition occurrences or observations of Stillbirth conceptset in females",,443213003,443213,,
443213000,17739,"Livebirth events, defined by condition occurrences or observations of Livebirth conceptset in females",,443213004,443213,,
443387000,17573,Malignant tumor of stomach referent incident cohort,"Persons with condition occurrence of referent concept (443387) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",443387001,443387,referent,
443387000,17572,Malignant tumor of stomach referent prevalent cohort,"Persons with condition occurrence of referent concept (443387) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",443387002,443387,referent,
443392000,17804,Malignant neoplastic disease referent incident cohort,"Persons with condition occurrence of referent concept (443392) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",443392001,443392,referent,
443392000,17803,Malignant neoplastic disease referent prevalent cohort,"Persons with condition occurrence of referent concept (443392) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",443392002,443392,referent,
443392000,17764,Malignant neoplasm excluding non-melanoma skin cancer prevalent cohort: Earliest of condition occurrence or observation of malignant neoplasms excluding non-melanoma skin cancer conceptset,,443392003,443392,,
443700000,18744,Eclampsia referent incident cohort,"Persons with condition occurrence of referent concept (443700) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",443700001,443700,referent,
443700000,18743,Eclampsia referent prevalent cohort,"Persons with condition occurrence of referent concept (443700) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",443700002,443700,referent,
443723000,17689,Thrombocytopenic disorder referent incident cohort,"Persons with condition occurrence of referent concept (432870) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",432870001,432870,referent,
443723000,17688,Thrombocytopenic disorder referent prevalent cohort,"Persons with condition occurrence of referent concept (432870) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",432870002,432870,referent,
443723000,18573,"Idiopathic thrombocytopenic purpura events, as defined by diagnosis codes from Shaw Platelets 2020",,432870003,432870,literature,
443723000,18576,"Thrombocytopenia events, as defined by diagnosis codes from Altomare ClinEpi 2016",,432870004,432870,literature,
443723000,17617,Pancytopenia referent incident cohort,"Persons with condition occurrence of referent concept (432881) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",432881001,432881,referent,
443723000,17616,Pancytopenia referent prevalent cohort,"Persons with condition occurrence of referent concept (432881) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",432881002,432881,referent,
443723000,17547,Leukopenia referent incident cohort,"Persons with condition occurrence of referent concept (435224) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",435224001,435224,referent,
443723000,17546,Leukopenia referent prevalent cohort,"Persons with condition occurrence of referent concept (435224) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",435224002,435224,referent,
443723000,17399,Anemia referent incident cohort,"Persons with condition occurrence of referent concept (439777) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",439777001,439777,referent,
443723000,17398,Anemia referent prevalent cohort,"Persons with condition occurrence of referent concept (439777) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",439777002,439777,referent,
443723000,20085,FDA AESI Immune thrombocytopenia (ITP) events,All events of Immune Thrombocytopenia with overlapping inpatient visit with no such events in prior clean window period (365 days). No continuous observation period requirement. Persons exit the cohort on start_date + 1 day.,439777003,4137430,study;FDA;Covid,
443723000,20086,FDA AESI Immune thrombocytopenia (ITP) event episodes for incidence characterization,All events of Immune Thrombocytopenia with overlapping inpatient visit. No continuous observation period requirement. Persons exit the cohort on start_date + 365 days.,439777004,4137430,study;FDA;Covid,
444247000,17707,Venous thrombosis referent incident cohort,"Persons with condition occurrence of referent concept (444247) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",444247001,444247,referent,
444247000,17706,Venous thrombosis referent prevalent cohort,"Persons with condition occurrence of referent concept (444247) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",444247002,444247,referent,
444247000,17731,"Venous thromboembolism events, defined by condition occurrences of Venous thromboembolism (pulmonary embolism and deep vein thrombosis) conceptset",,444247003,444247,,
444247000,18846,Pulmonary Venous Thromboembolism Alotaibi 1,"Venous Thromboembolism Alotaibi (2015) 1+ codes, in-patient",444247004,444247,literature,25834115
444247000,18847,Pulmonary Venous Thromboembolism Alotaibi 2,"Venous Thromboembolism Alotaibi (2015) 1+ codes, in-patient, first position",444247005,444247,literature,25834115
444247000,18848,Pulmonary Venous Thromboembolism McPeek Hinz 1,Venous Thromboembolism McPeek Hinz (2013) 1+ codes,444247006,444247,literature,24551388
444247000,18849,Venous Thromboembolism White 1,"Venous Thromboembolism White (2010) 1+ codes In-patient, Primary position",444247007,444247,literature,20430419
444247000,18850,Venous Thromboembolism White 2,"Venous Thromboembolism White (2010) 1+ codes In-patient, Secondary position",444247008,444247,literature,20430419
444429000,17509,Herpes simplex referent incident cohort,"Persons with condition occurrence of referent concept (444429) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",444429001,444429,referent,
444429000,17508,Herpes simplex referent prevalent cohort,"Persons with condition occurrence of referent concept (444429) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",444429002,444429,referent,
44784217000,17415,Atrial fibrillation referent incident cohort,"Persons with condition occurrence of referent concept (313217) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",313217001,313217,referent,
44784217000,17414,Atrial fibrillation referent prevalent cohort,"Persons with condition occurrence of referent concept (313217) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",313217002,313217,referent,
44784217000,17736,"Supraventricular arrythymia during hospitalization, defined by condition occurrences of Supraventricular arrythymia conceptset occurring between start and end of inpatient visit",,313217003,313217,,
44784217000,17746,"Cardiac arrhythmia during hospitalization, defined by condition occurrences, procedures, devices and drugs occurring between start and end of inpatient visit",,313217004,313217,,
44784217000,7399,"Cardiac arrhythmia prevalent cohort, defined by condition occurrence of Cardiac arrhythmia conceptset, with a second diagnosis or treatment anytime after",,313217005,313217,,
44784217000,17878,Atrial fibrillation design diagnostics 1 cohort,"First occurrence of Atrial fibrillation with descendants with >=365d prior observation, removing family history code",313217006,313217,design diagnostics,
44784217000,18866,Atrial Fibrillation Navar-Boggan 1,Atrial Fibrillation Navar-Boggan (2015) 1+ codes inpatient or 2+ codes outpatient or emergency department visits,313217007,313217,literature,
44784217000,17822,Ventricular tachycardia referent incident cohort,"Persons with condition occurrence of referent concept (4103295) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4103295001,4103295,referent,
44784217000,17821,Ventricular tachycardia referent prevalent cohort,"Persons with condition occurrence of referent concept (4103295) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4103295002,4103295,referent,
44784217000,17737,"ventricular arrhythmia or cardiac arrest during hospitalization, defined by condition occurrences of ventricular arrhythmia or cardiac arrest conceptset occurring between start and end of inpatient visit",,4103295003,4103295,,
44784217000,18626,Cardiac arrhythmia referent prevalent cohort,"Persons with condition occurrence of referent concept (44784217) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",44784217002,44784217,referent,
45763653000,17487,Fracture of bone of hip region referent incident cohort,"Persons with condition occurrence of referent concept (45763653) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",45763653001,45763653,referent,
45763653000,17486,Fracture of bone of hip region referent prevalent cohort,"Persons with condition occurrence of referent concept (45763653) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",45763653002,45763653,referent,
45763653000,17855,Fracture of bone of hip region (dx + px) referent concept incident cohort (aged 50-89),"This definition came from careful review of the following papers: o Ray WA, Griffin MR, Fought RL, Adams ML. Identification of fractures from computerized Medicare files. J Clin Epidemiol. 1992 Jul;45(7):703-14. PubMed PMID: 1619449. o Nair SS, Lenihan CR, Montez-Rath ME, Lowenberg DW, Chertow GM, Winkelmayer WC. Temporal trends in the incidence, treatment and outcomes of hip fracture after first kidney transplantation in the United States. Am J Transplant. 2014 Apr;14(4):943-951. doi: 10.1111/ajt.12652. Epub 2014 Feb 20. PubMed PMID: 24712332; PubMed Central PMCID: PMC4117735. o Hudson M, Avina-Zubieta A, Lacaille D, Bernatsky S, Lix L, Jean S. The validity of administrative data to identify hip fractures is high--a systematic review. J Clin Epidemiol. 2013 Mar;66(3):278-85. doi: 10.1016/j.jclinepi.2012.10.004. Review. PubMed PMID: 23347851.",45763653003,45763653,literature,
73553000,17611,Osteoarthritis referent incident cohort,"Persons with condition occurrence of referent concept (80180) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",80180001,80180,referent,
73553000,17610,Osteoarthritis referent prevalent cohort,"Persons with condition occurrence of referent concept (80180) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",80180002,80180,referent,
73553000,17665,Rheumatoid arthritis referent incident cohort,"Persons with condition occurrence of referent concept (80809) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",80809001,80809,referent,
73553000,17664,Rheumatoid arthritis referent prevalent cohort,"Persons with condition occurrence of referent concept (80809) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",80809002,80809,referent,
73553000,2538,Rheumatoid arthritis at first diagnosis (no history of Rheumatoid arthritis),Rheumatoid Arthritis at first diagnosis with 365 days continuous observation. Cohort exit is the end of continuous observable time for the person.,80809003,80809,,
73553000,18790,Rheumatoid Arthritis Hanly 1,Rheumatoid Arthritis Hanly (2015) 1+ codes,80809004,80809,literature,27790047
73553000,18791,Rheumatoid Arthritis Hanly 2,Rheumatoid Arthritis Hanly (2015) 2+ codes least 2 months apart,80809005,80809,literature,27790047
73553000,18792,Rheumatoid Arthritis Hanly 3,"Rheumatoid Arthritis Hanly (2015) 1+ codes, in-patient",80809006,80809,literature,27790047
73553000,18793,Rheumatoid Arthritis Ng 1,Rheumatoid Arthritis Ng (2012) 2+ codes,80809007,80809,literature,22623324
73553000,18794,Rheumatoid Arthritis Ng 2,Rheumatoid Arthritis Ng (2012) 2+ codes with at least one RA codes in a rheumatologist visit,80809008,80809,literature,22623324
73553000,18795,Rheumatoid Arthritis Ng 3,Rheumatoid Arthritis Ng (2012) 2+ codes with at least one rheumatology visit and with the last rheumatologist visit with a RA code,80809009,80809,literature,22623324
73553000,18796,Rheumatoid Arthritis Ng 4,Rheumatoid Arthritis Ng (2012) 2+ codes with 180D+ DMARD therapy,80809010,80809,literature,22623324
73553000,18797,Rheumatoid Arthritis Ng 5,Rheumatoid Arthritis Ng (2012) 2+ codes with at least one RA codes in a rheumatologist visit with 180D+ DMARD therapy,80809011,80809,literature,22623324
73553000,18798,Rheumatoid Arthritis Ng 6,Rheumatoid Arthritis Ng (2012) 2+ codes with at least one rheumatology visit and with the last rheumatologist visit with a RA codes with 180D+ DMARD therapy,80809012,80809,literature,22623324
73553000,18799,Rheumatoid Arthritis Widdifield 1,Rheumatoid Arthritis Widdifield (2014) 1+ codes,80809013,80809,literature,24956925
73553000,18800,Rheumatoid Arthritis Widdifield 2,"Rheumatoid Arthritis Widdifield (2014) 1+ codes, in-patient",80809014,80809,literature,24956925
73553000,18801,Rheumatoid Arthritis Widdifield 3,"Rheumatoid Arthritis Widdifield (2014) 1+ codes ever by a specialist (rheumatologist, internal medicine, orthopedic surgeon)",80809015,80809,literature,24956925
73553000,18802,Rheumatoid Arthritis Widdifield 4,Rheumatoid Arthritis Widdifield (2014) 2+ codes in 1 year,80809016,80809,literature,24956925
73553000,17639,Psoriasis with arthropathy referent incident cohort,"Persons with condition occurrence of referent concept (81931) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",81931001,81931,referent,
73553000,17638,Psoriasis with arthropathy referent prevalent cohort,"Persons with condition occurrence of referent concept (81931) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",81931002,81931,referent,
73553000,10607,"Psoriatic arthritis at first diagnosis from components (excluding dactylitis, mutilans)",Psoriatic arthritis defined by code or components at first diagnosis with 365 days of continous observation. Cohort exist is the end of continous observable time for the person.,81931003,81931,,
73553000,16918,Psoriatic arthritis,Psoriatic arthritis at first diagnosis with 365 days of continous observation. Cohort exist is the end of continous observable time for the person.,81931004,81931,,
73553000,17303,Psoriatic arthritis at first diagnosis from components,Psoriatic arthritis defined by code or components at first diagnosis with 365 days of continous observation. Cohort exist is the end of continous observable time for the person.,81931005,81931,,
73553000,17403,Ankylosing spondylitis referent incident cohort,"Persons with condition occurrence of referent concept (437082) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",437082001,437082,referent,
73553000,17402,Ankylosing spondylitis referent prevalent cohort,"Persons with condition occurrence of referent concept (437082) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",437082002,437082,referent,
73553000,10761,Ankylosing spondylitis or (inflammatory spondylopathy with investigations) indexed at earliest treatment,"All events of Ankylosing spondylitis or inflammatory spondylopathy with investigations with 365 days prior continuous observation, restricted to the earliest of having on of treatment (NSAIDs, Sulfasalazine, biologic or methotrexate) in the 90days before or after the index date. Cohort exit is the end of continuous observable time for the person.",437082004,437082,,
73553000,17140,Axial spondyloarthritis at first diagnosis,All events of Spondyloarthritis at first diagnosis with 365 days prior continuous observation. Cohort exit is the end of continuous observable time for the person.,437082005,437082,,
73553000,18871,Ankylosing spondylitis Curtis 2,Ankylosing spondylitis Curtis (2016) 2+ codes,437082006,437082,literature,27479952
73553000,18872,Ankylosing spondylitis Curtis 3,"Ankylosing spondylitis Curtis (2016) 1+ codes, rheumatology",437082007,437082,literature,27479952
73553000,18873,Ankylosing spondylitis Curtis 4,"Ankylosing spondylitis Curtis (2016) 2+ codes, rheumatology",437082008,437082,literature,27479952
73553000,18874,Ankylosing spondylitis Dubreuil 1,Ankylosing spondylitis Dubreuil (2017) 1+ codes,437082009,437082,literature,26762622
73553000,18875,Ankylosing spondylitis Dubreuil 2,Ankylosing spondylitis Dubreuil (2017) 2+ codes ? 7 days apart,437082010,437082,literature,26762622
73553000,18876,Ankylosing spondylitis Dubreuil 3,Ankylosing spondylitis Dubreuil (2017) 1+ codesandabsence of OA code,437082011,437082,literature,26762622
73553000,18877,Ankylosing spondylitis Dubreuil 4,Ankylosing spondylitis Dubreuil (2017) 1+ codesandabsence of RA code,437082012,437082,literature,26762622
73553000,18878,Ankylosing spondylitis Dubreuil 5,Ankylosing spondylitis Dubreuil (2017) 1+ codesandDMARD or Biologic,437082013,437082,literature,26762622
73553000,18879,Ankylosing spondylitis Dubreuil 6,Ankylosing spondylitis Dubreuil (2017) 1+ codesandNSAID,437082014,437082,literature,26762622
73553000,18870,Ankylosing spondylitis Curtis 1,Ankylosing spondylitis Curtis (2016) 2+ codes in primary care or 1+ codes in rheumatology,437082015,437082,literature,27479952
73553000,18614,Acute arthritis referent incident cohort,"Persons with condition occurrence of referent concept (4000634) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4000634001,4000634,referent,
73553000,18613,Acute arthritis referent prevalent cohort,"Persons with condition occurrence of referent concept (4000634) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4000634002,4000634,referent,
73553000,17539,Juvenile rheumatoid arthritis referent incident cohort,"Persons with condition occurrence of referent concept (4253901) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4253901001,4253901,referent,
73553000,17538,Juvenile rheumatoid arthritis referent prevalent cohort,"Persons with condition occurrence of referent concept (4253901) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4253901002,4253901,referent,
73553000,17061,Chronic arthritis among pediatrics at first diagnosis (restricted to age less than 18),Chronic arthritis at first diagnosis with persons limited to less than 18 years of age with 365 days continuous observation. Cohort exit is the end of continuous observable time for the person.,4253901003,4253901,,
73553000,17147,Juvenile Idiopathic arthritis at first diagnosis,Juvenile idiopathic arthritis at first diagnosis with 365 days continuous observation. Cohort exit is the end of continuous observable time for the person.,4253901004,4253901,,
80182000,17465,Dermatomyositis referent incident cohort,"Persons with condition occurrence of referent concept (80182) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",80182001,80182,referent,
80182000,17464,Dermatomyositis referent prevalent cohort,"Persons with condition occurrence of referent concept (80182) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",80182002,80182,referent,
80204000,18647,Fetal growth restriction referent incident cohort,"Persons with condition occurrence of referent concept (80204) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",80204001,80204,referent,
80204000,18646,Fetal growth restriction referent prevalent cohort,"Persons with condition occurrence of referent concept (80204) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",80204002,80204,referent,
80204000,18771,Fetal growth restriction events,"Fetal Growth Restriction reported in female, all events",80204003,80204,,
80502000,17613,Osteoporosis referent incident cohort,"Persons with condition occurrence of referent concept (80502) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",80502001,80502,referent,
80502000,17612,Osteoporosis referent prevalent cohort,"Persons with condition occurrence of referent concept (80502) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",80502002,80502,referent,
81902000,17701,Urinary tract infectious disease referent incident cohort,"Persons with condition occurrence of referent concept (81902) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",81902001,81902,referent,
81902000,17700,Urinary tract infectious disease referent prevalent cohort,"Persons with condition occurrence of referent concept (81902) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",81902002,81902,referent,
